ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001062.1|TLN-05220_1 # 1 # 885 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.703	BGC0001062.1|TLN-05220_1 	1	885	+	Loose	575	26.1794	LUT-3	24.18	3006945	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	LUT beta-lactamase	ATGGCTGACACCGACGGTCTGCTCGACGCCCGCAACTACGGCGGAACCGCTCCGACGGCCACGGGCTTCCACGTCAAGGGCGCCCACGCCCAGGACTGGGGCCTCCAGAACCGGTTGTCCCGGATCTTCCGGCCCGACAACGGCCGTACGGTGATGCTGGCCTTCGACCACGGCTACTTCGTCGGGCCGATGGCCGGCCTGGAGCGGCTCGACGCCACCATCGCTCCGCTTGTGCCGAGCGCCGACGCGATCATGATGACCCGGGGCGCGCTGCGCACCAGCATCCCGTCGCAGAGCAGCGCCGGGATCGTGCTGCGGGCCAGCGGCGGACCCAGCGTCCTGCGGGAACTTTCGGATGAGCACATCGCCCTGGACATCGAGGACGCGGTCCGGCTCAACGCCGCAGCGCTGGCGATCCAGGTATTCATCGGCGGCGAGCACGAGTCCCGGTCGGTGGCGAACCTCGCCGCCCTGGTGGACCGCGGGCAGCGACACGGGATCGCGGTGCTGGGCGTGACCGCCGTGGGCAAGGAGATGGTCCGCGACGCTCGCTACTTCCGGCTCGCCACCCGGATCAGCGCCGAGATGGGCGCGCACATCGTCAAGACTTACTACGTCGACCAGGGCTTCGAGACGGTGACCGCCAGCTGCCCGGTACCGATCATCGTGGCCGGCGGCAAGAAGCTGCCCGAGATCGACGCGCTGACCATGGCGTACCGCGCGATGCAGGAGGGCGCCGCGGGCGTCGACATGGGTCGCAACATCTTCCAGAGCGAGTACCCGGCCGCGATGCTGGCCGCGGTCCGTGCCGTGGTGCACGACGACGCCAAGCCCGCGGACGCCTACGAGCTCTTCCGGGAGCGGTCGGCCTCCTCCGCGTCCTGA	MADTDGLLDARNYGGTAPTATGFHVKGAHAQDWGLQNRLSRIFRPDNGRTVMLAFDHGYFVGPMAGLERLDATIAPLVPSADAIMMTRGALRTSIPSQSSAGIVLRASGGPSVLRELSDEHIALDIEDAVRLNAAALAIQVFIGGEHESRSVANLAALVDRGQRHGIAVLGVTAVGKEMVRDARYFRLATRISAEMGAHIVKTYYVDQGFETVTASCPVPIIVAGGKKLPEIDALTMAYRAMQEGAAGVDMGRNIFQSEYPAAMLAAVRAVVHDDAKPADAYELFRERSASSAS	MNVILNRRTFLLASAVVSASYSLGTLAGANRDDASFQDRLAKLEQKLNGRLGVCAIDTANGAQLGYRANERFAMNSTFKVMLASAFLARSQDEPGLLEERLMYTRADLVTYSPVTEKHVSTGMTVAELCAAGIQYSDNTAANVLMKKLGGPEAVTAFARSIGDTHFRLDRWETELNSAIPGDPRDTSTPQAMAMSLQRLALGDMLAADKQHQLQAWLKGNTTGGKRIRAGVPAGWQVGDKTGTGDYGSANDVAILWPPRRAPVVLALYSALENQQAEARNDVLADAARIVAEWVTG	99.32	gnl|BL_ORD_ID|3686|hsp_num:0	4756			81	534	
BGC0001062.1|TLN-05220_2 # 950 # 2611 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=6bp;gc_cont=0.723	BGC0001062.1|TLN-05220_2 	950	2611	+	Loose	500	27.335	FIM-1	36.84	3004786	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	FIM beta-lactamase	ATGTCACAACCACAGACCGGCGCCGACGACGTCGTCGACCTCGTGATCATCGGCGCCGGCATCAACGGCCTCGCCATCGCCCGAGACGCCGCCGACCGGGGTCTGAGCGTCGTCGTGGTCGACCGGGGGGACGTCGGCGCCGGCACCACCGCCACCTCCAGCCGGCTCATCCACGGCGGCCTGAAGTACCTCGAACGCTACGACTTCACCCTGGTGCACGAATCGATCCGGGAACGTCACCTGCTGTTCCGCACCGCGCCGCACCTGGTCCACGACTACCCCATGCTCATTCCGTTCTACGCCGGAGACAGCCGGCCCCGGGCCCTGGTCCGACTCGGCCTGGCCGCGTTCGACGTGCTGGCCGCCGGCCGGGGGCGCGGACGCAGCCGGGGCCTCTCCGCGCGGACCGTCGCCCGACGCTGGCCCCACCTCTGCCGTCAGGGGCTGCGCGGCGGGGTGCTCTTCAACGACGCCCAGGTGCCGTGGGCCGAGCGCCTCTGCGTCGAGTTGCTGATCGATGCCGAGCGGCTGGGCGCGCGGGTGCTGACCTACACCACGGTGACCAATCTTCTCGTCACGGACGGGCGGGTCCACGGCGTCCGGATCCGGGACAACCGGTCGGGGCGGACGGGGGAGATCCGGGGCCGCGTCACCGTCAACGCCGCCGGGCCGTGGATCGACCGGATCCTCGACAAGCAGGTGGCGAGCCGGCGGCTCAACGGTGGCACCAAGGGCAGCCACATCGTCATCGACCCGTTCCCGGGCGCCCCGGACACCTGCGTCTTCTTCGAGGCCGCCGCGGACCAGCGACCGATCTTCATCTTCCCGTGGGAGGGCCGCTACGTCCTCGGCAGCACCGACCTCACGTACGAGGGGGACCTGGACGAGGTCGTCGCCAGCGACGCCGAGATCGACTACCTGCTCACCGAGGCCAACCGGTTGTTCCCCCAGGCCGGTCTCACCCCGGCCGACGTGCTGTACAGCGTCGCCGGGATCCGCCCGCTGCCCTACACGGCCGGGGTGGCGGACAACGCCAAGATCAGTCGTGGGCACACCGTGCTCAACCACGCGCCCGCGTACGAGGGGCTGCTCACGATCATCGGCGGCAAGCTGACCACCCACCGTGCCCTCGCCGAGGACGCCACCGACGAGGCGCTGAAGGTGCTCGGTCGGCCGCGAGGACGGTGCACCACCCGTACCCGGCCGCTGCCCGGGGCCGACACGCCGGACTGGTACGCCTTCCGCGCGGACTTCGCGCGTTCGGCCACTCCGTTCACTCCGGCGCAGTCCGCCCGGCTGCTGGACATCTACGGCGTCCGGGCCCGCCGGGTGCTCGAACTCGTCGTGGCCGACCCGTCGCTGGCCGAGGTCGTCGACGAGCGTACCGGGGCGGTCGCCGCCGAGGTGGTCATGGCCTTCCGCGAGGAACGGGCCGTGACCTTGGCCGACGTGCTGCTGCGCCGTACGCTGGTCGGTCTCGGCCCGGACATGGCGGTGTCAACGGCCGTGACCTGCGCGGACGTCGCCGTACGGCAGCTCGGCTGGGACACCGGGCGGGCCGACGCCGAGGTGGCCGCGTACCGGGCGGAGCTGCGGCGTTTCCGCCCGCGCAAGCTGGACCTCGTCCCGGCGACCGGAACGAGCGAAGGGAGGGCGTCGTGA	MSQPQTGADDVVDLVIIGAGINGLAIARDAADRGLSVVVVDRGDVGAGTTATSSRLIHGGLKYLERYDFTLVHESIRERHLLFRTAPHLVHDYPMLIPFYAGDSRPRALVRLGLAAFDVLAAGRGRGRSRGLSARTVARRWPHLCRQGLRGGVLFNDAQVPWAERLCVELLIDAERLGARVLTYTTVTNLLVTDGRVHGVRIRDNRSGRTGEIRGRVTVNAAGPWIDRILDKQVASRRLNGGTKGSHIVIDPFPGAPDTCVFFEAAADQRPIFIFPWEGRYVLGSTDLTYEGDLDEVVASDAEIDYLLTEANRLFPQAGLTPADVLYSVAGIRPLPYTAGVADNAKISRGHTVLNHAPAYEGLLTIIGGKLTTHRALAEDATDEALKVLGRPRGRCTTRTRPLPGADTPDWYAFRADFARSATPFTPAQSARLLDIYGVRARRVLELVVADPSLAEVVDERTGAVAAEVVMAFREERAVTLADVLLRRTLVGLGPDMAVSTAVTCADVAVRQLGWDTGRADAEVAAYRAELRRFRPRKLDLVPATGTSEGRAS	MRPLPHSYLKSLVICLLTAFAALTPVVNSGVQAAQPKDVPVTFTAITQGVWMHTSMKHMENWGHVPSNGLIVEKGDFSILVDTAWDDPQTAQIIEWSKDTLKKPIRWAVFTHAHDDKMGGVAALRQQGIVTYAAADSNRMAPQNGLTPAEHDLIFDSEHSTSVLHPLVIFDPGPGHTRDNIVVGLPEQGIVFGGCLIRPSGSTSLGNTADADLAHWKTAVLAVAQRFAEAQQIIPSHGPMAGRELFELTAQLAEKASIPSTP	211.07	gnl|BL_ORD_ID|2173|hsp_num:0	3584			387	501	
BGC0001062.1|TLN-05220_3 # 2608 # 4131 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=6bp;gc_cont=0.757	BGC0001062.1|TLN-05220_3 	2608	4131	+	Loose	275	28.4906	vanN	31.91	3002912	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	GTGACGATCCCGCACACCTGCTACCTCGGGGTCGACGTCGGCCTCACCGCCACCAAGGTGGCCGCCTTCGACGTCGTCGGCGACGAGCTGGCCGTCGTGCACGCCCGCACGCCCCGCACCAGCGTCACCGCCCACCGCCACGACGTCGACATGACCGCCCTCGCGGACACGGTGCTGTCGCTGCTGGCGGAGGTCGGCGGCAAGCTGGCCGCCGACGGGTACGCCCCGGCGGGCATCGGTGTGGCCGCACACGGCAACGGCATCTACCCGGTCGACGGGGCCCTGCGGCCGGTCGGGCCGGCCATCGCCTCGTCGGACAGCCGGGCGCAGCACATCGTCCAGGCGATCCCGCCGGAGGGGGCCCGCCGGCTGGCCCGGGAGACCGGCTCGATCCCGTGGGCCGCCCAGCCCGCCGTCCTGCTGCGCTGGCTGCGGGACGCCGAACCGGCGGCCTACGCCGCCACCCGGTGGGTGCTGTCCTGCAAGGACTGGGTCACCGCGCAGCTCACCGGCGTGGCCAGCGCGGACTACAGCGATGCCAGCGCGTTCGGCATGGTCGGGCTCGACACCCGCGCGTACAGCCCGACGGCGCTCGAACTGGTCGGCCTGCCCGCCACCGACCTGGACCGGTTCCCGCCGCTGCTCAGGTCCGACGAGGTGGTCGCCGGACTGAGCGCGGCGACGGCGGCCCGCACGGGGCTGCCCGAGGGCCTGCCGGTCATCGCCGGGTGCATGGACTGCGTGGCCGCCACCCTCGGCGCCGGGGGACGGGCGCCCGGGGACGGCACGATCATCGTCGGCACGTGGGCGATCAACGGGGTGGTGGTGCCCGCACGCACCCCCGCCCCGGAGGTCACGCTCAGCGCGTTCATGCCCGATCCGGCCACCATGCTGGCCATGGAGGTGGCCCCCACGTCGGCCGCCAACCTCGAATGGCTCGCCGGCGCCGGGGTGCCCCACCAGCAGACCGGCGGCGTCGCCGCGGCGGAACTGCTCCAGGAGGCCGCCACCGTGCCGCCCGGCGCCGACGGTCTGTTGTTCCTGCCTTTCGTCAACGGCTCACCGGAACACCCGTCGGCGTCCGGCACGTTCCTCGGCATCTCCAGCAACCACCGCCGGGGCCACCTGACCCGCGCGGTCATCGAAGGCGTCGCGCAGTACCACCGGGTGCAGATCGACCGGGTGCTGGCCAGCGGCGCGGACGTCGGTGACCGACCCTGGCGGCTGGCCGGCGGGGGCGCGCGGTCGACGGTGTGGGCGCAGATCTTCGCCGACGTGCTCGGCCGCCCGGTCCGGCGGCAGCTCACCAGCGAACTCGGCGCCCGGGGCGTCGCCTCGCTGCTGCCCGCCGCCCTCGGCCACGACGTGCCGCCGTGGACCGTCAACGACGAGGACGACCTCTGCGTGCGCCCGGGGCCCGACCGCGCCGCCTACCGGGAGCATGCCCAGGTGTTCGACCGCTGCCTCGCCCGCATGTCCGCGGTGTGGTCGGAGGTCGAGCGCCACCCGGGCAGGAGCGCCTGA	MTIPHTCYLGVDVGLTATKVAAFDVVGDELAVVHARTPRTSVTAHRHDVDMTALADTVLSLLAEVGGKLAADGYAPAGIGVAAHGNGIYPVDGALRPVGPAIASSDSRAQHIVQAIPPEGARRLARETGSIPWAAQPAVLLRWLRDAEPAAYAATRWVLSCKDWVTAQLTGVASADYSDASAFGMVGLDTRAYSPTALELVGLPATDLDRFPPLLRSDEVVAGLSAATAARTGLPEGLPVIAGCMDCVAATLGAGGRAPGDGTIIVGTWAINGVVVPARTPAPEVTLSAFMPDPATMLAMEVAPTSAANLEWLAGAGVPHQQTGGVAAAELLQEAATVPPGADGLLFLPFVNGSPEHPSASGTFLGISSNHRRGHLTRAVIEGVAQYHRVQIDRVLASGADVGDRPWRLAGGGARSTVWAQIFADVLGRPVRRQLTSELGARGVASLLPAALGHDVPPWTVNDEDDLCVRPGPDRAAYREHAQVFDRCLARMSAVWSEVERHPGRSA	MKKIALIFGGTSAEYEVSLKSAASVLSVLENLNVEIYRIGIASNGKWYLTFSDNETIANDLWLQDKKLNEITPSFDGRGFYDQAEKVYFKPDVLFPMLHGGTGENGTLQGVFECMQIPYVGCGVASSAICMNKYLLHQFAKSVGVMSTPTQLISSTDEQQVIKNFTELYGFPIFIKPNEAGSSKGISKVHTEAELTKALTEAFQFSQTVILQKAVSGVEIGCAILGNDQLLVGECDEVSLATDFFDYTEKYQMTTAKLTVPAKIPVATSREIKRQAQLLYQLLGCQGLARIDFFLTEAGEILLNEINTMPGFTNHSRFPAMMAATGITYQELISTLITLAEDK	147.81	gnl|BL_ORD_ID|143|hsp_num:0	164			525	663	vancomycin
BGC0001062.1|TLN-05220_5 # 6372 # 8258 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.774	BGC0001062.1|TLN-05220_5 	6372	8258	-	Loose	500	26.9498	CTX-M-219	46.67	3005642	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	ATGGCAGCGACTGACGCCGCGATCGTGTGGTGGGCGGTCGGACCGTCGGGGCAGGAGGACCGGGGGGCCACCGGCCGCGCGGCGACCGTCGCGGCGGTGTTCGACCGGCTCGGCCCGACCGTACGGCGGGGTCGGCGGACCTCGCTCGTGCTGACCGGCACGACCACCCCGGTCGGGTACGAGGGCGGGGTCGGGTCGGTCTGCGTACCGCCGGGTGTGGCCGGGTCGACGGTGGTCGTACCCCGGCTCTGCGCGGCGCTGCACCACGCGGCGGCCCTGCTGGGTCGGGCGGAGGCCGACCTCACCCTGGTCGCCGCCGAGTTGGACGACGAGCCGGGACGGTGGCTGGTGGTGGCGCTGCGTCGCCTCGCCGAGTCCTGGTCGCCCGACGAGCCGCCGCTGGCGGTCGTCCGGACCACCGACGGCCTCACCGAGGCCGGCCGTACCCGTTCCGGCGTGCTCCGCCCCGGCGACCTGCGCCGCATGCTGGCCGACGGCTGCCGCCGCCCGAACCCGGTCGCCGACCACCGCGCCCCCACCCCGGTCGCGCTGCCGGACACCTCCCGGCGGGGACACTCGGTGCTCCTGCTGCCGCCGCCCGCGCCGGTACCCCCGGCCGGCGACCCGCTGGTGATCCGCTGGTCGACCGTCGACGAGGCGACCGGTGAGCGGCGACGCCGGGCGATGGGGCGGCTGGCCCGCTTCGAGGGCGACCTGTTCGGCGACGACCGGCGGCGGGTCGAGACGCTGGCCCGGCACGCGCCCCGCCGGGCCACCCCCGGGGGCGTACGCGGCGCGGTCGTGGCGGCCGACGCCGCCGAGGCGGCCGGGGCCCTGGAGCGGCACCGGCCCGCGGTGCCGAAGCAGCGCCCGGTCGCGCTGCTCTTCCCCGGCCAGGGTGCGCAGTACCCACGCATGGGTGCCGGCCTCTACGGCCACGACCCGGTCTTCACCACCGCGATGGACACGTTCTTCACCCTCTGGGGCGAGGGCGGCCAGCGGTTGCGCGAGGAGTGGCTCTCCGACGACCCGAGCGTCCCCTTCGACGACGGCTCCCGGGCCCAGCCGCTGCTCTTCGGCGTCGGCTACGCGCTCGGCGCGATGGTCCGCTCCTGGGGGGTCCGCCCGGTCGCCCTGCTCGGGCACAGCGCCGGGGAGATGGTCGCCGCCACCCTGGCCGGGGCGTTCAGCCTGCCCGCCGCCGTCCGGCTGATGCGGGCCCGGGTCACCGAGGTGCTGCGTACCCCGCCCGGCGGCATGCTCGCCGTCGCGGCCACCGCCGACGAACTCCAGCCCTACCTGACGCTGGACCCGACCGGGCAGGTCGCCGTCGCCGCCGTCAACGCCCCCCGGCAGACCATGCTGGCCGGTCCGGACGAGGCGCTGGCCGTGGTCCAGGAGAAGCTGCGCGAGCAGGGGTACATCTGCCGGCTGGCAAAGGCCCGCCAGGCGTTCCACAGCCCGGCCGTGCTGGACGCGTCGCTGGCCACCCGGCCCGCGGTCGAGGCGGCCCGGCCCGGCCCGCCGGTCGACACGGTCTACTCCGCGTACGTGGGACGGAAGCTGGACGCCGCCACCGCCGACGACCCGATGTTCTGGACCACCCAGATCGCCGACCCGGTGCTCTTCTGGCCGGCGCTCGACGCGCTGCTCGCCACCGGTGACCTGCTGCTCGTGGAGGCCGGTGCCGGTCAGGGGCTGACCAACGTGGCCCGCCAGCACCGCGCGGTGCGGTCGAAGGCCAGTGACGTGGTGGCGCTGCTGCCGGCCTCGCCCGGTGCGCCGGTCGCCGACCGCAGGAGCGTCCTCGCCGCCGCCGCGCGGATCTGGGCCGAGGGCCACGAACTCCGGTGGGAGGCGGTGGACGGCACGACCGCCCGCCCCTGA	MAATDAAIVWWAVGPSGQEDRGATGRAATVAAVFDRLGPTVRRGRRTSLVLTGTTTPVGYEGGVGSVCVPPGVAGSTVVVPRLCAALHHAAALLGRAEADLTLVAAELDDEPGRWLVVALRRLAESWSPDEPPLAVVRTTDGLTEAGRTRSGVLRPGDLRRMLADGCRRPNPVADHRAPTPVALPDTSRRGHSVLLLPPPAPVPPAGDPLVIRWSTVDEATGERRRRAMGRLARFEGDLFGDDRRRVETLARHAPRRATPGGVRGAVVAADAAEAAGALERHRPAVPKQRPVALLFPGQGAQYPRMGAGLYGHDPVFTTAMDTFFTLWGEGGQRLREEWLSDDPSVPFDDGSRAQPLLFGVGYALGAMVRSWGVRPVALLGHSAGEMVAATLAGAFSLPAAVRLMRARVTEVLRTPPGGMLAVAATADELQPYLTLDPTGQVAVAAVNAPRQTMLAGPDEALAVVQEKLREQGYICRLAKARQAFHSPAVLDASLATRPAVEAARPGPPVDTVYSAYVGRKLDAATADDPMFWTTQIADPVLFWPALDALLATGDLLLVEAGAGQGLTNVARQHRAVRSKASDVVALLPASPGAPVADRRSVLAAAARIWAEGHELRWEAVDGTTARP	MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQVLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTESTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGSGDYGTTNDIAVIWPQGRAPLVLVIYFTQPQQNAESRRDVLASAARIIAEGL	215.81	gnl|BL_ORD_ID|3479|hsp_num:0	4548			780	870	
BGC0001062.1|TLN-05220_7 # 9750 # 11234 # -1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.731	BGC0001062.1|TLN-05220_7 	9750	11234	-	Loose	1050	293.123	facT	42.99	3001313	protein homolog model	n/a	n/a	elfamycin antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGGTGACCCCACTCCCGGCCGCCGCCACCGCCCCTGCCGCCGCCACCGCCCCTGCCGCCGGCGCTCCGTCGCCCGCGCGGCGGCTCGGCCCCGCGCTGACCGTGGTGCTCCTGGCGACCTTCATGACCAGTTTCGACACCACCGGCGTGAACATCGCCGTGCCGTCCATCCAGGACGGGCTGGGCGCGAGCTACGCCTCGATGCAGTGGGTCCTCGCCGGGTACACCCTGCCGTTCGCCCTGTTGCTGGTCACCGGGGGCCGGATCGGCGACGCCTTCGGCCGTCGGCGGGCGTTCCTGGTCGGGCTCGCCGGCTTCACCGTCGCCTCGGTGCTCGCCGGAGTCGCCGGCGACGTCGGCTGGCTCGTCGCCGCCCGGGTGGTGCAGGGCGTCGCCGCCGCGATCATGGGTCCGCAGGTCCTCGCGGTCTTCCAGGTCCTGGTGCCGCCCGCCCGCCGGGCCCCGCTGCTCGCCGTCTACGGCCTGGTCATCGGCCTGGCCACGGTCTCCGGCCCGATGCTCGGCGGCATCCTGATGGGCGCCGACCTGTTCGGCTGGGGTTGGCGCACCATCTTCCTGATCAACCTGCCGATCGGCCTGGCGGCCCTCGTCGGCGGGCTCTTCTGGCTGCCCGAGTCCCGGGACGAGCGGGGGCGCGGCTTCGACCTCGGCGGTGTCTTCCTGGCCGCCGCCGCACTGCTGCTCCTGCTGCACCCCCTCATGTACGGCCGGGAACTCGGCTGGCCGTGGTGGTCCTGGGTGTGCCTGGCCGCCGCCGGCCCGGCGTTCGTGCTGCTCGTCCGGTTCGAGCGGCGCAAGGAGCAGGCCGGGGAGTCGCCGCTGGTGGCGCTGCACCTGTTCGGGCAGCGCACGTTCACCGCCGGGGTGCTCGCGAACGTCATCGTCGCGGCGCTGATGTCCGGCTTCTTCCTGACCTTCGTGGTGTTCCTCCAGAACGGTCTGGGCTTCACCGCCGAACGCACCGGCTGGACGGTCGCACCCTGGGCGATCGGCACCGCGCTCGCCTCGATGGTGGCGATCCCGCTGGCCCGTACCGCCGGGCGGACCGCGCTGGTGGTCGGCGCGATCCTGATGACGCTCGGCATGGCCGGGCTGAACGCGATCGTGGTCGTCTCCGGCGACCGGCTCACCTCGCTGCCGATCGTGGTCAGCCTCTGCGTCGTCGGCATCGGCATGGGCCTGGTCAGCGCCCCGATCCTCAACGTCACCCTGGCCGGCATCCCGCACGTCGACGCCGGTTCCGCCGCCGGCATCTTCTCCACCGGCAAGCAGACCGGCGGGGTGTTCGGGGTGGCGGTGACCGGTGCGGTCTTCTTCGGCCTCCTCGCCGACCAGGACACCGCGAGCCGGGCGCGGTTCGTCGACGCGATGAGCTGGACCCTCGGTGTGCAGGTGGTGCTCTGCCTCCTGGTCGTGGCACTGGTCTTCGTCTTGCCCCGCAAGGTGGACGCCACCGCCCGCTGA	MVTPLPAAATAPAAATAPAAGAPSPARRLGPALTVVLLATFMTSFDTTGVNIAVPSIQDGLGASYASMQWVLAGYTLPFALLLVTGGRIGDAFGRRRAFLVGLAGFTVASVLAGVAGDVGWLVAARVVQGVAAAIMGPQVLAVFQVLVPPARRAPLLAVYGLVIGLATVSGPMLGGILMGADLFGWGWRTIFLINLPIGLAALVGGLFWLPESRDERGRGFDLGGVFLAAAALLLLLHPLMYGRELGWPWWSWVCLAAAGPAFVLLVRFERRKEQAGESPLVALHLFGQRTFTAGVLANVIVAALMSGFFLTFVVFLQNGLGFTAERTGWTVAPWAIGTALASMVAIPLARTAGRTALVVGAILMTLGMAGLNAIVVVSGDRLTSLPIVVSLCVVGIGMGLVSAPILNVTLAGIPHVDAGSAAGIFSTGKQTGGVFGVAVTGAVFFGLLADQDTASRARFVDAMSWTLGVQVVLCLLVVALVFVLPRKVDATAR	MNKAGQAEKPAAAGPPATPETPEPDPKRWLALTVLLVATFMDLLDANIITVAIPSIQRDLGASTFAIQAMTAGYTLSFAVLLITGGRLGDIFGRKRMFLVGVGGFVLASAMCAAAPSTDLLVVARALQGLTAAVMVPQVLALIHVSFAPQEIGRVVSLYASMVGLAIVSGPLIGGALISWNPLDLGWRSIFVVNLPVGVLALVGAAKWMRESSSPHAKRLDIAGMLLIVLGLLLLMVPLTLGRELDWPVWSIVSLVAAAPVLVLFVVYERHKTAKDGSPLVTLSLFKVRAFGAGIGVQLLFSAIPAGFFLSWTLYLQAGLGWSALHTGLTAIPFSLCVPIVGGLAVRRLSPLYGRYCLLAGAVLMLAGILSYAWAADRFGTDITSWHAIPSMLLIGSGMGMLMPPLTALVLREVQPQEAGAASGIINATGQLGAALGVAVIGSLFFAALAGNAGPQAERVAPTVQSVSPRQASDLRDCATEALGQDDLAKVPDICSTLVQGADDGTRDTINGALGEIRAKTFVSTYSETLYWAAGGLVPVTALVLLLPHHRVRREEPAQ	88.37	gnl|BL_ORD_ID|1345|hsp_num:0	1469			72	1350	factumycin
BGC0001062.1|TLN-05220_8 # 11264 # 11731 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=3bp;gc_cont=0.694	BGC0001062.1|TLN-05220_8 	11264	11731	-	Loose	700	24.2534	DHA-16	35.29	3002147	protein homolog model	n/a	n/a	cephalosporin; cephamycin	antibiotic inactivation	DHA beta-lactamase	ATGAGAGAGACAATTGCCCAGGCGCTGGCGGTGGTCGCCGTCGGCGGCAGCGGGATCGTGGCGGGGGTGTTCTTCGCCGTGGCGGTGAGCGTGCTGCCCACCCTCTACACCATGCCCGCGGGCAGCTACATCACCCTGCACCGCAAACTCGGCCAGGGGTACCACCCGTCGATGCCGTTGATCGTCAACTCGACGATGTTCGCCGACATCGCACTGATCTTCCTGGTCGAGGAGACAACGACCCGGTGGCTGTTCATCCTGGCCTCGGTGCTGGCGCTGGGCGTGCAGGGGGTGTCCCACCTCGGCAACGTCCCGATCAACAAGCGGGTGCTCCGGGTCGACCCGGACGCCGTACCCGACGACTGGGACGACCCCCGACCCCAGTGGCGGCGCCTGCACCAGCTGCGGACCGCGCTGGCCCTGGCGGCCCTGACGGTGACCGCGGCGGGCGTGGTGGTGCTGCCGTGA	MRETIAQALAVVAVGGSGIVAGVFFAVAVSVLPTLYTMPAGSYITLHRKLGQGYHPSMPLIVNSTMFADIALIFLVEETTTRWLFILASVLALGVQGVSHLGNVPINKRVLRVDPDAVPDDWDDPRPQWRRLHQLRTALALAALTVTAAGVVVLP	MKKSLSATLVSALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKETSLNDPAVKYQPELTQPQWKGITLLDLATYTAGGLPLQVPEAVKSSEDLLHFYQQWQPSWQPGKMRLYANSSIGLFGALTATAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNNQPVRVTGGPLDAESYGVKSASKDMLRWAEINMSPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE	40.90	gnl|BL_ORD_ID|383|hsp_num:0	423			189	408	
BGC0001062.1|TLN-05220_10 # 13986 # 14990 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=8bp;gc_cont=0.689	BGC0001062.1|TLN-05220_10 	13986	14990	+	Loose	400	26.5646	ErmU	34.78	3001305	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGGGAACCAAGACCTCTGACCTGTCGATCCTCGACCTCGCGGCGGGCTACTGGTCGGCCAAGACCTTTCTCAGCGCGGTCGAGCTGGGCCTGTTCGGCGTCCTCGCCGAGGGCGGCAAGACCGAGCCGGAGATCCGCGAGACGCTCGGGCTGCACCCCCGGGCCACCCGCGACTTCCTCGACTCGCTGGTCGCGCTTAAGGTGCTCGACCGCGACGCTGAGGGCCGCTACGCGATCAGCGCCGCCGCCGCCAACCAGCTCGACCCGAAGCACCCGTCGTACCAGGGCGGCTTCCTCCGCATGCACGCCTGGCAGTACGGCGTCTGGGGCAAGCTGACCGACCTGCTGAAGACCGGTGACATGCAGGCGCACACCGACCGCGACTTCAACAAGTTCTACTCGCGGCCGGAGTCGGTGCGGAACTTCATGTCCGCCATGGACGGTGCCAACTCGGCCGTCGGTCCGGCGCTGGCGGAGAAGTTCGACTGGACCGAGGTCGGCTCCTTCGTGGACGTCGGCGGCGCACGGGGCAACATCGCCGCGGTGATCGCCAAGGCCCACCCGCAGCTGGACGCCGGCACCTTCGACCTGCCGCCGGTGAAGCCGTTCTTCGACGAGCACATGGACCGGCTGGGCATGACCGACCGGGTCACCTTCCACGCCGGTGACTTCTTCAACGACAGCCTCCCCACCGCCGACGTCCTGATCTTCGGGCACGTGCTGCACGACTGGAACGACGAGCAGCGGATCGCCCTGCTGCGCAAGGCGTACGAGGCGCTGCCGGTCGGCGGTCGGGTCATGGTGTACGACGCCCTGATCGACGACGACCGCCGGGAGCCGGCGAACCTGCTGCTCAGCCTCAACATGCAGCTGGTCACCCCGGGCGGTGGCGAGTACACCGGCGCGGACTGCCAGGGTTGGATGCGCGAGGCCGGCTTCACCGAGACCTCGGTCCTGCCGTTGACCGACGCAGACTCGGCCGTGATCGGGCGCAAGACCGCCTGA	MGTKTSDLSILDLAAGYWSAKTFLSAVELGLFGVLAEGGKTEPEIRETLGLHPRATRDFLDSLVALKVLDRDAEGRYAISAAAANQLDPKHPSYQGGFLRMHAWQYGVWGKLTDLLKTGDMQAHTDRDFNKFYSRPESVRNFMSAMDGANSAVGPALAEKFDWTEVGSFVDVGGARGNIAAVIAKAHPQLDAGTFDLPPVKPFFDEHMDRLGMTDRVTFHAGDFFNDSLPTADVLIFGHVLHDWNDEQRIALLRKAYEALPVGGRVMVYDALIDDDRREPANLLLSLNMQLVTPGGGEYTGADCQGWMREAGFTETSVLPLTDADSAVIGRKTA	MPSRYGSRQDLGQNFLVDPDIIKLIRRAPNERKVPSLIWRRRGHVTLPLSRLGRPVTAVELDPRRVKRLSARAPENVKVVGEDILRFRLPTVPHTVVGNIPFHVTTATMRRILVAPAWVSAVLVVQWEVARRRAGIGGCSLVTAESWPWFDFSVLKRVPRFAFRPAPSVDGGILVIERRPEPLVRERREYQAFVRQVFTGRGHGLREILQRIGRVQDSDLSAWFRAHGVSPQALPKDLTAEQWASLWGMARGGRSVPRTRRPRGLPPRTSRGPRRNSG	120.14	gnl|BL_ORD_ID|325|hsp_num:0	356			708	813	lincomycin
BGC0001062.1|TLN-05220_12 # 16035 # 16772 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=5bp;gc_cont=0.730	BGC0001062.1|TLN-05220_12 	16035	16772	+	Loose	400	29.6462	ErmW	37.18	3001306	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGGATCTTCAACTGGCCGGCAAGCGCGCACTGGTCACGGGTGGCACCCGCGGCATCGGACGCGCGATCGTCACCGCCCTGGCCGGGGCCGGCGCCTCGGTCGTCACCTGCTACCGCCACGACCGTGAGGCGGCGGAGAGCCTCGAGCGGGAGCTGAAGGCGACCGACGGCAGGCACCAGGTGGTCCAGGCCGACCTGCGCGACCCGGCGGAGGTGACGCGCCTCGTCGAGGTCGCGAAGTCCGAGCTGGGCGGGCTGGACATCGTGGTCAACAGCGCCGGGGTGGACAGCCACGCGCCGGCCGCCGAGGTGACCCTCGACGAGTGGCGACGGGTGCTGGACACCAACCTGACCGCGTTCCACCTGGTCACCCACGCCGCCCTGCCGCTGCTCGGCGCGGGCGCGTCGATCGTCAACGTCGGCGCCTCGGTGAGCACCCGGGGCCTGGCCGGCAAGGCGCACTACACCGCCAGCAAGGCCGCCATCAACGGCTGGATGCGGTCGGTGTGCAAGGAGGTCGGCCCGCGCGGCATCCGGATCAACGAGGTCTCCCCGGGCATCATCGAGACCGAGCCGGGCGCCGGCCTGCCGCCGGAGATGTACGAGCGGATCAAGTCCAACGCCGCGCTGCGTCGCCTGGGCACCTCGGAGGACGTGGCGAACGCCGTGCTCCTGCTGGCCAGCCCGCTGGCCGCGTACGTGACCGGGGCGACCCTGCACGTCGACGGCGGCATCTGA	MDLQLAGKRALVTGGTRGIGRAIVTALAGAGASVVTCYRHDREAAESLERELKATDGRHQVVQADLRDPAEVTRLVEVAKSELGGLDIVVNSAGVDSHAPAAEVTLDEWRRVLDTNLTAFHLVTHAALPLLGAGASIVNVGASVSTRGLAGKAHYTASKAAINGWMRSVCKEVGPRGIRINEVSPGIIETEPGAGLPPEMYERIKSNAALRRLGTSEDVANAVLLLASPLAAYVTGATLHVDGGI	MSSIRRRHAAASLDTPAVGGRHELGQNFLVDRGVCTRIAEVVSSTTAHPVLELGAGDGAITRALVAANLPVTALELDPRRVRRLQRTFADGVTVVHGDMLRYDFGPYPHHVVSTVPFSITTPLLRRLIGQRFWHTAVLLVQWEVARKRAGVGGTTMLTAASWPWYEFTLVERVPKTSFDPVPSVDGGILVIERRSAPLLDDRCVGDYQNLVREVYTGPGRGLAAILRTRLPGREVDAWLRRERVDPAALPRDLKAGHWASLYRLYREVGTRPAPAGRSVRARPGSVGPDRSLPPRGLRSGPPRARRRGGGA	78.78	gnl|BL_ORD_ID|1572|hsp_num:0	1714			18	243	erythromycin; josamycin
BGC0001062.1|TLN-05220_13 # 16772 # 17647 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.733	BGC0001062.1|TLN-05220_13 	16772	17647	+	Loose	750	29.261	tet(X6)	32.5	3005056	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGGCCGCCCGAAAGGTGGCCGTCCTCGGACTGGGCGGCATGGGCGGCGGCATGGCGCACCGGCTGCTGGACAGCGGCGTCGAGCTGACCGTCTGGAACCGCACCGCGGCGAAGGCCGCCGGGCTGGTGGCGGCCGGCGCGCGGCAGGCGGACTCGCCGGCCGAGGCGGTCGCCGACGCCGACGTGGTCCTGGTCAGTCTCGCTGACGAGGAGGCCGTCGAGCAGGTCCTCTTCGGCGCGGTGTGCCCGGCGGCCCGGCCGGGGACACCGATCATCGACACCTCCACGGTCTCCCCCACGTACGCCCGGGAGGCGGGCGAGCGGGCGGCGAAGGCGGGGGTGAAGCGGATCGAGGCGTGCGTGGTCGGCAACCCGCACCAGGCGCGCAACGGCGAGCTGCGGGTGCTGACCGCCGGCACCCAGGCCGACCTGGCCGAGGTGAGCGACGTGCTCGCCCTGCTCGGTCCACAGGTGGTCTACCTGGGCCCACCCGGGATGGCCGCCACCATGAAGCTGGTCTTCAACGCCATGCTCGGCGCCCAGGTCGCCTCGATGGCCGAGGCGGTCGCCTACGGCGAGCGCTCCGGCCTGGACCGGGACATGCTGCTGATGGCGGTGGAGCGCAGCGGCTTCAGCTCCAAGGTGATGTCGTTCCGGGCCGCGCTGATGCGCGAGCGCAAGTACGAGCCGGCCGCCTTCCGGACCCGGCTGATGAACAAGGACCTCCGTCTCGCCCTCGCGGAGGCGGCCAAGGTGGGCGTGGACATGCCGGTCATCGAGCGGTCCGCGGTCACCTTCACCGAGGCGATCGACGCGGGCTACGGCGACCAGGACGCCGCCGCGGTGCACGAGATGCTCAGCCGTAACGACGCCTGA	MAARKVAVLGLGGMGGGMAHRLLDSGVELTVWNRTAAKAAGLVAAGARQADSPAEAVADADVVLVSLADEEAVEQVLFGAVCPAARPGTPIIDTSTVSPTYAREAGERAAKAGVKRIEACVVGNPHQARNGELRVLTAGTQADLAEVSDVLALLGPQVVYLGPPGMAATMKLVFNAMLGAQVASMAEAVAYGERSGLDRDMLLMAVERSGFSSKVMSFRAALMRERKYEPAAFRTRLMNKDLRLALAEAAKVGVDMPVIERSAVTFTEAIDAGYGDQDAAAVHEMLSRNDA	MTLLKHKKITIIGAGPVGLTMARLLQQNGVDITVYERDKDQDARIFGGTLDLHRDSGQEAMKRAGLLQTYYDLALPMGVNIVDEKGNILTTKNVRPENRFDNPEINRNDLRTILLNSLQNDTVIWDRKLVTLEPDKEKWILTFEDKSSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKSKTRVDFQDRNSVVDFLLKKFSDWDERYKELIRLTSSFVGLATRIFPLDKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFAYGREAQAESIINETEMFSLDFSFQKLMNL	76.98	gnl|BL_ORD_ID|4802|hsp_num:0	3797			9	129	tetracycline; minocycline; oxytetracycline
BGC0001062.1|TLN-05220_15 # 18127 # 18603 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.669	BGC0001062.1|TLN-05220_15 	18127	18603	+	Loose	650	24.6386	vanS gene in vanO cluster	48.39	3002941	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	ATGACCGTCACCGGGGCCGGCACCGCAGGCCGAGAGGAGAAAACCGTGACCACCACGAGCGCCACGAAGGTTTCGTGGAGCGACGTACAGCCGAACCGTCGGCGCGGCGGTGATGTCCGTATCATGCTCAGCCCGAAGACGGTGAAGTCGACGACCGGATTCGGCGGAATGCTCACCCTGGAGCCGGGCGAATTCGTGTGCGAGCACATCCACCCGTATTCCGAGGAGTCCATCTACGTGGTGAGCGGTCAGATCACCATGCGGATCGACACCGAGTACGTGGACCTCGGTCCGGGTGAGGCGTGCCTGGTGCCGATCAACGTCAAGCACCGGGTGGAGAACCGCGGCCAGGAGCCGGCCCAGGTGATCTTCCACCTCTGCCCGCTGGCGCCCCGCCCCGAGCTGGGGCACATCGACACCGAGTTCCTGCCCGGCCGGGAGAACGAGCCGGCGCCCCAGGTCGGAGGGCACCTGTGA	MTVTGAGTAGREEKTVTTTSATKVSWSDVQPNRRRGGDVRIMLSPKTVKSTTGFGGMLTLEPGEFVCEHIHPYSEESIYVVSGQITMRIDTEYVDLGPGEACLVPINVKHRVENRGQEPAQVIFHLCPLAPRPELGHIDTEFLPGRENEPAPQVGGHL	MLAGVLLLAAVWVFLLRGRSTNFQFPALADFARVFDPSNFGPVVFVPAAILALGFLLVFGLVGGWILAGRMLAPLARITRAAREAGSGSLSYRIELEGRNDEFRELADAFDAMLARLEARDAAQQRFAANASHELRTPLAITQTLLDVARNDPNRDGGELDERLRAVNARAIELTEALLLLSRTDQRSFSREDVDLSLIAEEAAETLLPFAEKHGVSIETSGDIAPVIGSHALLLQLTTNLLHNAIVHNVPEHGSVQISTAIGSESVMLTVENTGDKLSPQLVSTLTEPFQRGTARTRGDDARVGLGLAIVKSITQAHDGSLTLSPRAAGGLSVAVRLPAAQRRP	45.80	gnl|BL_ORD_ID|4732|hsp_num:0	465			885	978	vancomycin
BGC0001062.1|TLN-05220_16 # 18600 # 19871 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=7bp;gc_cont=0.713	BGC0001062.1|TLN-05220_16 	18600	19871	+	Loose	700	28.1054	PDC-108	27.27	3006486	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	GTGAGCACACCGCGCGTCGCGGTCACCGGCATCGGCGTGATGGCGCCCGGCGGCGTGGGCCGCCAGGCGTTCTGGGACATGATGACCGCCGGCCGGACCGCCACCCGACGCATCACCTTCTTCGATCCGTCGAACTTCCGCTGCCAGGTCGCCGCCGAGATCGACTTCGACCCGGCGAAGATGGGCCTGACCCCGCAGGAGGTCCGCCGGATGGACCGGGCCGCCCAGCTGGCCGTACTGGCCACCCGGGAGGCGGTGGAGGACAGCGGGCTGACCCTGGACGACCTCAACCCGACCCGCACGGCGGTCACCGTCGGCAACGCGGTCGGCTGCACGATGGGCCTGGAGACCGAGTACACCGTCGTCTCCGACGGCGGTCGCAAGTGGATCGTCGACCACGAGTACGCCGTCCCCGAGATGTACGACTACTTCGCGCCCAGCTCGCTGGCGCGCGAGGTGGCCTGGGCGACCCGTGCCGAGGGCCCCGCGTCGGTGGTCTCCTCCGGCTGCACCTCCGGCATCGACGCCCTCGGCTACGCGGCCAACCTGATCCGGGAGGGCACGGCGGACATCGTCATCGCCGGCTCGACCGACGCGCCGATCTCGCCGATCACGGTGGCCTGCTTCGACGCGATCCGGGCGACGTCGACCTTCAACGACAGCCCGGAGTCGGCCTGCCGGCCGTTCGACGGCAACCGGCGCGGCCTGATCCTCGGTGAGGGCGCGGCGATGTTCGTGCTGGAGAGCACCGAGTCGGCCCGCCGCCGGGGCGCGCCGATCTACTGCGAGATCGCCGGCTACGCGACCCGGGCCAACGGCTTCCACATGACCGGCCTCAAGCCGGACGGGCGGGAGATGGCCGAGGCGATCCGGCTGAGCATGGCCCAGGCGAAGCTCAACCCGGAGGACATCGACTACGTCAACGCGCACGGCTCGGGCACCAAGCAGAACGACCGGCACGAGACGGCGGCGGTCAAGGCCAGCCTCGGCCAGCACGCCTACGCCACCCCGATGAGCTCCATCAAGTCGATGGTCGGTCACTCGCTCGGCGCGATCGGCTCGATCGAGGTCGCCGCCTGCGCGCTGGCCGTCAAGCACAACGTGGTGCCCCCCACGGCCAACCTGACCACCAGGGACCCCGAGTGCGACCTGGACTACGTACCGATGATCGCGCGTGAGCACCGCACCGACGCCGCGCTCTCCGTGGGCAGCGGGTTCGGTGGCTTCCAGAGCGCGATCCTGGTCGTCGACCCCGAGGCGGTGCCGGCATGA	MSTPRVAVTGIGVMAPGGVGRQAFWDMMTAGRTATRRITFFDPSNFRCQVAAEIDFDPAKMGLTPQEVRRMDRAAQLAVLATREAVEDSGLTLDDLNPTRTAVTVGNAVGCTMGLETEYTVVSDGGRKWIVDHEYAVPEMYDYFAPSSLAREVAWATRAEGPASVVSSGCTSGIDALGYAANLIREGTADIVIAGSTDAPISPITVACFDAIRATSTFNDSPESACRPFDGNRRGLILGEGAAMFVLESTESARRRGAPIYCEIAGYATRANGFHMTGLKPDGREMAEAIRLSMAQAKLNPEDIDYVNAHGSGTKQNDRHETAAVKASLGQHAYATPMSSIKSMVGHSLGAIGSIEVAACALAVKHNVVPPTANLTTRDPECDLDYVPMIAREHRTDAALSVGSGFGGFQSAILVVDPEAVPA	MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQGLDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR	106.55	gnl|BL_ORD_ID|4176|hsp_num:0	5246			747	945	
BGC0001062.1|TLN-05220_17 # 19883 # 21085 # 1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.727	BGC0001062.1|TLN-05220_17 	19883	21085	+	Loose	500	29.261	OXA-85	23.73	3001780	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGACCGGCCTGGGTGTCATGGCGCCCAACGGCATGGACACCGAGACCTACTGGTCGTCCATCCTGGACGGCAAGAGCGGCATCAACCGCATCCAGCGGTTCGACGCCCCGCGCTACCCGGTGAAGCTCGCCGGCGAGCTGGCCACCTTCGACCCGGCCGAGCACGTGCCGAGCCGGTTGCTGGTGGAGACCTCGGCCATGAGCCACCTGGCGTTCGTGGCCGCCGAAATGGCGATCAAGGACGCCGAGGTCGACCTGACCCAGCTCCCCGAGTACGAGATCGGCGTGATCACGGCGAACGCCACCGGTGGCGTCGAGGTCGGCCAGCGGGAGCTGGAGAAGCTCTGGACGCAGGGCCCGGAGCACGTCAGCGCGTACATGTCGATCGCCTGGTTCTACGCGGCCACCACCGGGCAGCTCTCCATCCGGCACAAGCTGCGCGGGCACTGCGGCGTGGTGGTGTCCGAGCAGGCCGGCGGCCTGGACGCGATCGGCCACGGCCGGCGGGTGCTGCGGCAGAACCACCAGCTCGTCCTGGTCGGCGGCACCGAGTCGGCGATGTCGCCGGCCGGTGTGGTGGCCCAGATGCCCACCGGCAACCTGAGCCACAGCGACATCCCGGACGCGGCGTTCCTCCCGTTCGACGTGCGGGCGGGCGGCTACGTCCCGGGTGAGGGCGGCGCGATCCTGGTGGTCGAGGACGCCGAGACCGCCCGTCGGCGCGGCGCCCCGCGGATCTACGGGGAGATCGCCGGCTACGCGGCCACCTTCGACCCCCGCCCGGGCGGGGACCGCAAGCCGACGCTGGAGCAGGCGGCCCGGCTGGCGCTGGCCGACGCGGGCGTCCAGCCCCGCGACGTCGACGTGGTCTTCGCCGACGCGTACGGCGTGCCGGAGCTGGACCGGATCGAGGCCGCTGCGATCAGCGCGATCTTCGGCCCGAACAGCGTGCCGGTGACCGCGCCGAAGACGATGACCGGCCGGATCTACGCCGGTGCCGGTGCCCTCGACACGGTCGGCGCGCTGCTGTCCATCCGGGACGGCGTGATCCCGCCGACGATCAACGTCGAAACCCTCGCCCCCGGCTGCGACATCGACCTCGTCCGGGAGCGCCCCCGAACCGCGCCGGTGCGCACCGCGCTGGTGCTCGGCCGCGGGCACGGCGGGTTCAACTCCGCCGTCGTCGTCCGTGCCACCTCGTAA	MTGLGVMAPNGMDTETYWSSILDGKSGINRIQRFDAPRYPVKLAGELATFDPAEHVPSRLLVETSAMSHLAFVAAEMAIKDAEVDLTQLPEYEIGVITANATGGVEVGQRELEKLWTQGPEHVSAYMSIAWFYAATTGQLSIRHKLRGHCGVVVSEQAGGLDAIGHGRRVLRQNHQLVLVGGTESAMSPAGVVAQMPTGNLSHSDIPDAAFLPFDVRAGGYVPGEGGAILVVEDAETARRRGAPRIYGEIAGYAATFDPRPGGDRKPTLEQAARLALADAGVQPRDVDVVFADAYGVPELDRIEAAAISAIFGPNSVPVTAPKTMTGRIYAGAGALDTVGALLSIRDGVIPPTINVETLAPGCDIDLVRERPRTAPVRTALVLGRGHGGFNSAVVVRATS	MLLFMFSIISFGNENQFMKEIFERKGLNGTFVVYDLKNDKIDYYNLDRANERFYPASSFKIFNTLIGLENGIVKNVDEMFYYYDGSKVFLDSWAKDSNLRYAIKVSQVPAYKKLARELGKERMQEGLNKLNYGNKEIGSEIDKFWLEGPLKISAMEQVKLLNLLSQSKLPFKLENQEQVKDITILEKKDDFILHGKTGWATDNIVVPIGWFVGWIETSDNIYSFAINLDISDSKFLPKREEIVREYFKNINVIK	157.48	gnl|BL_ORD_ID|260|hsp_num:0	289			396	711	cloxacillin; oxacillin; cefalotin
BGC0001062.1|TLN-05220_18 # 21118 # 21375 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.682	BGC0001062.1|TLN-05220_18 	21118	21375	+	Loose	1200	25.409	LRA-13	28.21	3002484	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	class C LRA beta-lactamase; class D LRA beta-lactamase	ATGCGTGAGATGACCCTGGACGACCTGACGCGCGTGATCCGCGCGACGGTGGGCGTGGACGACTCGGTCGACCTGACCGCCGACATCCACGACACCCTCTTCACCGACCTCGGCTACGACTCGCTGGCCCTGCTCGAGGTGGTCAGCCGGCTGGAGAAGGAGTTCCCGGCCTCGGTTCCCGAGGAGATGATCGGCGAGCTGCGCACCCCGCGCGAGCTGATCGAGTTCGTCAACGACCAGCTCGCCCCGGCGGCGTGA	MREMTLDDLTRVIRATVGVDDSVDLTADIHDTLFTDLGYDSLALLEVVSRLEKEFPASVPEEMIGELRTPRELIEFVNDQLAPAA	MNFRHIVMAALCGLAWTPAIHATEVCIAIAEAGTGAVLVQRGDCQRQVTPASTFKIAISLMGYDSGFLKDAHAPKLPFRPGYVDWRPSWREPTDPAKWMSDSVVWYSQQVTKSLGMQRFADYTRNFKYGNADVSGDAENDGLSMSWISSSLRISPLEQLAFLDKIVNRRLGVSAHAYDMTAQLTKFDQPPAGWRINGKTGAASGYGWYVGWASKGSRTFVFAHLMQRDATQPQDVSAGVLARDEFLKELPGLMIKDMVDRAVQPLMKKYDIPGMAVAVTDNGKNYFFNYGLASRETGQAVTSHTLFEIGSLSKTMAATLTSYAQVNGQLALTDTVSRHMPKLRGGGFDKISLLNLGTHTAGDFPMQVPDHIETYEQLMEYYKNWKPGVAAGGARTYSNLTVGLLGIITAQSMGMPFAEAMENRLFPQLGMHHSYINVPAAEMKNYAQGYNQANAPVRINPAVLATEAYGVKTDAADLIRFVDANMGLVKLDEKLQRAVTGTHTAYFKTGELTQDLIWEQYPAASKLDRMLAGVSEKMVFESNPATRLAPPMPPQADVLINKTGSTGGFGAYALFNPGKKTGIVMLANKSYPGAERVTAAWHILDQLDQR	13.96	gnl|BL_ORD_ID|1764|hsp_num:0	1912			1035	1140	
BGC0001062.1|TLN-05220_19 # 21378 # 21836 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.671	BGC0001062.1|TLN-05220_19 	21378	21836	+	Loose	2300	25.409	evgS	24.62	3000833	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCCAAGAAGACGGAGTGCGCCGTCGTCATCGACGCGCCGATGGACCTGGTCTGGGACATGACCAACGACGTGCCGAACTGGCCGGACCTCTTCACCGAGTACGCCGCGGCGGAGGTGCTGGAGCGGGACGGGAACACCATCCGGTTCCGGCTGACCATGCACCCCGACGAGAACGGCCGGGTGAACACCTGGGTCTCCGAGCGGACCTCCGACGCGGCCACCCGGACCGTCCGGGCGCACCGGATCGAGACCGGCCCGTTCGACTTCATGAACATCTTCTGGGCGTACCGGGAGGTCGACGGCGGCGTGGAGATGCGCTGGGAGCAGGAGTTCCACGTCAAGGACGAGATGCCCTTCGACGACGACGCCATGGCCGCGCACCTGCTGAAGAACTCGGCCATCCAGATGGCGGCCATCAAGGAACGGATCGAGAAGGCCGCCGTCGCCCGCTCCTGA	MAKKTECAVVIDAPMDLVWDMTNDVPNWPDLFTEYAAAEVLERDGNTIRFRLTMHPDENGRVNTWVSERTSDAATRTVRAHRIETGPFDFMNIFWAYREVDGGVEMRWEQEFHVKDEMPFDDDAMAAHLLKNSAIQMAAIKERIEKAAVARS	MKFLPYIFLLCCGLWSTISFADEDYIEYRGISSNNRVTLDPLRLSNKELRWLASKKNLVIAVHKSQTATLLHTDSQQRVRGINADYLNLLKRALNIKLTLREYADHQKAMDALAEGEVDIVLSHLVTSPPLNNDIAATKPLIITFPALVTTLHDSMRPLTSPKPVNIARVANYPPDEVIHQSFPKATIISFTNLYQALASVSAGHNDYFIGSNIITSSMISRYFTHSLNVVKYYNSPRQYNFFLTRKESVILNEVLNRFVDALTNEVRYEVSQNWLDTGNLAFLNKPLELTEHEKQWIKQHPNLKVLENPYSPPYSMTDENGSVRGVMGDILNIITLQTGLNFSPITVSHNIHAGTQLSPGGWDIIPGAIYSEDRENNVLFAEAFITTPYVFVMQKAPDSEQTLKKGMKVAIPYYYELHSQLKEMYPEVEWIQVDNASAAFHKVKEGELDALVATQLNSRYMIDHYYPNELYHFLIPGVPNASLSFAFPRGEPELKDIINKALNAIPPSEVLRLTEKWIKMPNVTIDTWDLYSEQFYIVTTLSVLLVGSSLLWGFYLLRSVRRRKVIQGDLENQISFRKALSDSLPNPTYVVNWQGNVISHNSAFEHYFTADYYKNAMLPLENSDSPFKDVFSNAHEVTAETKENRTIYTQVFEIDNGIEKRCINHWHTLCNLPASDNAVYICGWQDITETRDLINALEVEKNKAIKATVAKSQFLATMSHEIRTPISSIMGFLELLSGSGLSKEQRVEAISLAYATGQSLLGLIGEILDVDKIESGNYQLQPQWVDIPTLVQNTCHSFGAIAASKSIALSCSSTFPEHYLVKIDPQAFKQVLSNLLSNALKFTTEGAVKITTSLGHIDDNHAVIKMTIMDSGSGLSQEEQQQLFKRYSQTSAGRQQTGSGLGLMICKELIKNMQGDLSLESHPGIGTTFTITIPVEISQQVATVEAKAEQPITLPEKLSILIADDHPTNRLLLKRQLNLLGYDVDEATDGVQALHKVSMQHYDLLITDVNMPNMDGFELTRKLREQNSSLPIWGLTANAQANEREKGLSCGMNLCLFKPLTLDVLKTHLSQLHQVAHIAPQYRHLDIEALKNNTANDLQLMQEILMTFQHETHKDLPAAFQALEAGDNRTFHQCIHRIHGAANILNLQKLINISHQLEITPVSDDSKPEILQLLNSVKEHIAELDQEIAVFCQKND	12.70	gnl|BL_ORD_ID|1214|hsp_num:0	1318			1845	2040	erythromycin; cloxacillin; tetracycline; oxacillin; norfloxacin
BGC0001062.1|TLN-05220_20 # 21865 # 22614 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=5bp;gc_cont=0.705	BGC0001062.1|TLN-05220_20 	21865	22614	+	Loose	700	25.7942	OmpA	33.33	3005044	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	General Bacterial Porin with reduced permeability to peptide antibiotics	ATGGAACAGCTACTTGCCGGCAAGAACGCCCTGGTCACCGGCGGTACGCGCGGCATCGGCCGGGCGATCGTGCTGACCCTGGCGAAGGCCGGCGCGAACGTGGTGACCTGCTACCGCTCCGAGGGCGAGGCCGTGGAGAGCCTGGCCCGCGAGCTGAAGGACACCCCGGGGCAGCACCACCTGGTCCGCGCCGACGTCGGTGACGCGGAGCAGATCGACCAGCTGCTGGCCGAGTGCAAGGTCCGCCTCGGCGGCCTGGACGTGGTGGTCAACAACGCCGGCGTGATCAGCCACATCGGCTACGACGACCTGTCGCTGGCCGACTGGCACGCGGTCGTCGACACCAACCTGACCGGCACCTTCCTGGTCATCCAGAAGGCCCTGCCGCTGATGGGCGAGGGCGCGTCCGTGGTCAACATCGGCTCCCGGGTGGCCAAGGTGGGCATCCCGATGCGGGCGCACTACACCGCCGCCAAGGCCGGCCTGGTGGGTCTGACCCGCTCGCTCTGCAAGGAGCTGGGCCGCCGGGGCATCCGGGTGAACCTGGTCGAGCCGGGCGTCATCGCGACCGAGGAGATGGCGCGCCTGACCCCGGAGCAGCGGGCCGCCATGGAGGCCCGCTACGCGCAGCTCACCTCGCTCGGCCGGCTCGGTGACCCGGACGAGGTCGCCGAGGTCGTGCTCTTCCTCGCCAGTGACAAGTCCCGCTACGTCAGTGGCGCGCAAATCCCCGTCGACGGAGGTATCTGA	MEQLLAGKNALVTGGTRGIGRAIVLTLAKAGANVVTCYRSEGEAVESLARELKDTPGQHHLVRADVGDAEQIDQLLAECKVRLGGLDVVVNNAGVISHIGYDDLSLADWHAVVDTNLTGTFLVIQKALPLMGEGASVVNIGSRVAKVGIPMRAHYTAAKAGLVGLTRSLCKELGRRGIRVNLVEPGVIATEEMARLTPEQRAAMEARYAQLTSLGRLGDPDEVAEVVLFLASDKSRYVSGAQIPVDGGI	MRSFVTSWRILDDNEAQKMKKTAIAIAVALAGFATVAQAAPKDNTWYAGGKLGWSQYHDTGFYGNGFQNNNGPTRNDQLGAGAFGGYQVNPYLGFEMGYDWLGRMAYKGSVDNGAFKAQGVQLTAKLGYPITDDLDIYTRLGGMVWRADSKGNYASTGVSRSEHDTGVSPVFAGGVEWAVTRDIATRLEYQWVNNIGDAGTVGTRPDNGMLSLGVSYRFGQEDAAPVVAPAPAPAPEVATKHFTLKSDVLFNFNKATLKPEGQQALDQLYTQLSNMDPKDGSAVVLGYTDRIGSEAYNQQLSEKRAQSVVDYLVAKGIPAGKISARGMGESTPVTGNTCDNVKARAALIDCLAPDRRVEIEVKGYKEVVTQPAA	66.58	gnl|BL_ORD_ID|2774|hsp_num:0	3787			744	858	polymyxin B; defensin
BGC0001062.1|TLN-05220_21 # 22617 # 22949 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.661	BGC0001062.1|TLN-05220_21 	22617	22949	+	Loose	300	24.6386	tet(36)	50.0	3000197	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAGCAACCCTGCGTTCCGGGTCATGCTGCGGTTCGACATCAACCCGGGGATGGAGGCCGACTTCGAGCAGACCTGGCTCTCCATCGGCAGCGTCATCACCGACCACCCGGCCAACCTCGGGCAGTGGCTGATGAAGGACTCCCAGCAGGACTCGACCTACTACGTCATCAGCGACTGGGTGGACGAGCCGCGGTTCCGGGAGTTCGAGCACAGCGACGAGCACGTGGAGCACCGCAAGAAGCTGCACCCGTTCCGGCACGGCGGCGCGATGTTCACCATGAACGTCGTGTTCGCGCTGCCGGCCGGCGAGGCCGCGAAGGCCCTGCGGTGA	MSNPAFRVMLRFDINPGMEADFEQTWLSIGSVITDHPANLGQWLMKDSQQDSTYYVISDWVDEPRFREFEHSDEHVEHRKKLHPFRHGGAMFTMNVVFALPAGEAAKALR	MRTINIGILAHIDAGKTSITENLLFASGATIVRGSVDKGNTTTDSMDIEKRRGITVRASTTSIQWNDTKINIIDTPGHMDFLAEVERTFRMLDGAILVVSAKEGIQAQTRLLFNVLQQLEIPTILFVNKIDREGVNLNQLYLEIQNSLSKDIIFMQSVEGKELTSSCTIHYISEKNRETILEKDDLLLEKYLSDTQLSNLDYWNSMVRLVQAAKLHPIYHGSAMYGIGIEDLLNSITTFIETSLPQENALSAYVYKIEHNKKEQKRAYLKIIGGTLKSRKLYSLNGSDENLKIRGLKTFYSGDEIDVDEVFTNDIAIADHADNLMVGDYLGIMPNLFDKLNIPSPALKSSIHPAKVENRSKLISAMNVLSVEDPSLAFSINADNNELEVSLYGATQREVILTLLEERFSVDAYFEEVKTIYKERLKTKSEYTIHIEVPPNPYWASIGLIIEPLPIGAGLVMESEISLGYLNRSFQNAVFDGVKKACESGLYGWEVTDLKVTFSHGIYYSPVSTPADFRSLAPYVFRLALQQADVELLEPILDFKLQIPLAVNARAITDINKMQGEISTITSDGDWTTILGNIPLDTSKEYSAEVSSYTQGLGVFVTRFSGYRPTNKKVSRSVELNEKDKLMYMFEKESIK	17.19	gnl|BL_ORD_ID|1675|hsp_num:0	1708			639	687	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0001062.1|TLN-05220_22 # 22973 # 23260 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.694	BGC0001062.1|TLN-05220_22 	22973	23260	+	Loose	300	24.6386	AAC(3)-IIb	45.45	3002534	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGGTGTGGCACCGCGCGCCGGCCGACGACGCCGACGCGGTGGCCAAGGCGTACGACCAGATCAGCCGGCACCTGGAGGGGACTCCGGGGCTCATCGGCAACGAACTGCTCCGGTCCACGAAGGACCCGCACCGCCTGGTGGTGCTCAGCGAGTGGGAGAGCCTGGAGGCGTTCCGGGTCTGGGAGGAGGGCGTCTCGCACCGCCCCTCCACCTCTCCCCTGCGGCAGTACCAGGACCGCGAGCAGGAGAACTTCTTCGAGGTCTTCGAGGTGTCGGCGGCGTTCTGA	MVWHRAPADDADAVAKAYDQISRHLEGTPGLIGNELLRSTKDPHRLVVLSEWESLEAFRVWEEGVSHRPSTSPLRQYQDREQENFFEVFEVSAAF	MNTIESITADLHGLGVRPGDLIMVHASLKAVGPVEGGAASVVSALRAAVGSAGTLMGYASWDRSPYEETLNGARMDEELRRRWPPFDLATSGTYPGFGLLNRFLLEAPDARRSAHPDASMVAVGPLAATLTEPHRLGQALGEGSPLERFVGHGGKVLLLGAPLDSVTVLHYAEAIAPIPNKRRVTYEMPMLGPDGRVRWELAEDFDSNGILDCFAVDGKPDAVETIAKAYVELGRHREGIVGRAPSYLFEAQDIVSFGVTYLEQHFGAP	35.32	gnl|BL_ORD_ID|850|hsp_num:0	925			660	726	dibekacin; sisomicin; netilmicin; tobramycin; 6'-N-ethylnetilmicin; 2'-N-ethylnetilmicin; gentamicin
BGC0001062.1|TLN-05220_24 # 24221 # 25297 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.733	BGC0001062.1|TLN-05220_24 	24221	25297	+	Loose	500	29.261	OXA-60	39.02	3001808	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAAGGTCGAGAACCTGTACGTCGTCGGCACCGGGCGTCGCCTGTCCCCGGCGATGACGCTGGAGGAGGCCGAACGGGCCGGGCTCTGCGAGCGCCGGCTGGTCTGGCGTACCGAGATGCAGTCGGTCTGCGTGAGCGAGGGCGAGTCCGGTCCGGAGATGGCCGCGCACGCCGCGCGGACCGCGATCCGGCAGGCCGGGGCACGGCCGGCGGAGATCGACCTGATCCTGCACGCCAACACCTGGTACCAGGGGCACGACATGTGGGCTCCCGCCTCGTACGTGCAGCGCGAGGCGGTGGGCAACTCCTGCCCGGCCATCGAGGTGCGGCAGATGTCCAACGGGGGCCTCTGCGCGCTGGAGCTGGCGGTGGGCTACCTGCTCGGCGACCCGACGCGGACCAGCGCGCTGGTCACCACCGGGGACCGGTTCTGCGCGCCGGGCTTCGACCGCTGGCGCAGCGACCCGGGCACCGTCTTCGGCGACGCCGGCACCGCCGTCGTCGTGTCCCGCCGGCCCGGGTTCGCCCGGCTGCGCAGCATCGTCACCGTCGCCGACTCCGGGCTGGAACAGATGCAGCGCGGGGTGGACCCGTTCGGCCCGGTGCCGTTCAGCGCCCGGGCCACCGTGGACGTGGAGTCGCTGCGCCAGGCCTTCGTCCGGTCCAGCGGGCTCGACGGCATCCTCGACCGGATCGACCGGGGCCAGTCCGAGGCGATCGAACGGGCCCTCGCCGACGCCGAGGTGACCCTCGACGACATCGACTGGTTCGTCCTGCCGAACCTCGGGCGGGGCCGGCTCAACGCCCACTTCCTGCACAAGTTCAAGATCGACCCCGACCGGACCACCTGGTCCTGGGGACGCCAGGTCGGACACCTCGGGGCCGGCGACCAGATCGCCGGGCTGGGGCAGATCGCCGACTCCGGCGTCCTGCAACCCGGTCAGCGGTGCCTCCTCGCCGGCGTGGGCGCGGGATTCACCTGGTCGTGCGCCGTGGTCGAGATGCTCCGCAGGCCACCCACCGCCAGCCGCCCGGCCACGTCGGCCGGTCTCACCCGCACCGCGAGAAGGGGTTGA	MKVENLYVVGTGRRLSPAMTLEEAERAGLCERRLVWRTEMQSVCVSEGESGPEMAAHAARTAIRQAGARPAEIDLILHANTWYQGHDMWAPASYVQREAVGNSCPAIEVRQMSNGGLCALELAVGYLLGDPTRTSALVTTGDRFCAPGFDRWRSDPGTVFGDAGTAVVVSRRPGFARLRSIVTVADSGLEQMQRGVDPFGPVPFSARATVDVESLRQAFVRSSGLDGILDRIDRGQSEAIERALADAEVTLDDIDWFVLPNLGRGRLNAHFLHKFKIDPDRTTWSWGRQVGHLGAGDQIAGLGQIADSGVLQPGQRCLLAGVGAGFTWSCAVVEMLRRPPTASRPATSAGLTRTARRG	MLSRYSKTLAFAVVACTLAISTATAHAELVVRNDLKRVFDDAGVSGTFVLMDITADRTYVVDPARAARSIHPASTFKIPNSLIAFDTGAVRDDQEVLPYGGKPQPYEQWEHDMALPEAIRLSAVPIYQEVARRVGFERMQAYVDAFDYGNRQLGSAIDQFWLRGPLEISAFEEARFTSRMALKQLPVKPRTWDMVQRMLLIEQQGDAALYAKTGVATEYQPEIGWWAGWVERAGHVYAFALNIDMPREGDMAKRIPLGKQLMRALEVWPAP	132.10	gnl|BL_ORD_ID|38|hsp_num:0	47			387	510	cloxacillin; oxacillin; cefalotin
BGC0001062.1|TLN-05220_25 # 25306 # 26832 # 1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=7bp;gc_cont=0.708	BGC0001062.1|TLN-05220_25 	25306	26832	+	Loose	990	32.7278	qacA	25.42	3003046	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACCTCGACAGCCACACCGATCCCGCCCACCGAAAAGACCTTCCTCGGCCAGCCGCGCTGGTTCGGCACCCTCTTCGTCGTCGACATGTGGGAGCGGTTCAGCTTCTACGGCATGCTCGCCATCCTGGCGCTGTTCCTGGTCGCCAGTCCGGCCGACGGCGGCATGGGCATGTCCGAGGTGGACGCCGCCGCGCTCTTCGGCATGTACATGTCCCTGGTGTTCATGGCCGCCCTGCCGGGCGGCTGGCTCGCCGACCGGGTGCTCGGCGCGCGGCGGGCCACCCTCTGGGGTGGCATCTTCATCACCGCCGGGCACGTCTTCCTCTCCGTGCCCGCGGAACCCACCCTCTACCTGGGGCTGGGCTGCATCATCGTCGGCACCGGCCTGGTCAAGCCGAGCATGGCGGCGATGGTCGGCGACATGTACCAGGGCCAGCCCGAGCGGCGGGAGGCGGCCTTCTCGCTGTTCTACATGAGCGTCCAGGTCAGCGCCCTGCTCGCCCCGCTGATCACCGGCTTCGCCGCGGAAAAGATCAACTGGCACCTGGGCTTCGGGATCGCCGCGTTCGGCATGGTCGTCGGCCTGATCCAGTACGTGGTCGGGATGCGCAGTCTCGGTGACGTCGGCTCCCGCCCGTCGAACCCCGCCCCACCGGAGGTGCGGGCCCGCGTCTGGCGACGCTCGGCGATCTTCGGTGGGATCCCGGCGGTGCTCGCCGTCGTCGGCGTGGCCAGCGGGGCGGTCGCCCTCCAGCAGGTGCTGATGCTCCTCGGCCTGATGGTGCTCGGCGTGCCGATCGTCTACTGGATCCGGCTCAACCGCCGGCCGGAGATCGCGCCCTACCGGGTCCGGCTGCGCGCGTTCCTCTGGATGCTGATCGCCTCCGCGTTCTTCTGGATGCTCTACGCCCAGGGCCCCGCCCTGATGAACATCTTCGCCAAGGACTCGGTCGACCGGGACGTGTTCGGCTTCGAGGTGCCGGCGAGCTGGTTCCAGTCGGCCCAGCCGCTGTTCCTGCTGATGCTCGCCCCGGCCTTCGCCGCCCTCTGGGTGCGGCTGGGCTCCCGGGTGGCGGTACCGCCGAAGTTCGTCGCCGGCATGCTCCTCGGCGGCGTCTCGTTCGTCATCATGGCGGTCGCCGCCTCGCTGGCCGAGAGCGGCCCGGTGTCCCCGCTGTGGCTGCTCACCGTCTACCTGATCATCGTCTGCGGCGAGCTGGTGGTGGCGCCGGTCGGGCTCAGCCTGGCCGCCCAGGTGGCCCCGCCGGGCTTCTCCAGCCAGATGATCGGCCTGTTCTGGCTCTTCGCGGCGGTCGGCGCGGCCACCGGCGGCCAGCTCGCCGGGATCACCGCAGTGGTCTCCGACGCCACCTTCTACCTGGTGCTCGGCGGCGTCGGACTCGCCGTGGCGGCGGCTCTGGCGTTCTCCGTCCGCTCGCTGACGCGACGCCTCGCCGACGAGCCCGTACCGGACAAGCCGACGACGACGCAGTCGCCGGTCGAGGGCGTGACCTCCCTGCACTGA	MTSTATPIPPTEKTFLGQPRWFGTLFVVDMWERFSFYGMLAILALFLVASPADGGMGMSEVDAAALFGMYMSLVFMAALPGGWLADRVLGARRATLWGGIFITAGHVFLSVPAEPTLYLGLGCIIVGTGLVKPSMAAMVGDMYQGQPERREAAFSLFYMSVQVSALLAPLITGFAAEKINWHLGFGIAAFGMVVGLIQYVVGMRSLGDVGSRPSNPAPPEVRARVWRRSAIFGGIPAVLAVVGVASGAVALQQVLMLLGLMVLGVPIVYWIRLNRRPEIAPYRVRLRAFLWMLIASAFFWMLYAQGPALMNIFAKDSVDRDVFGFEVPASWFQSAQPLFLLMLAPAFAALWVRLGSRVAVPPKFVAGMLLGGVSFVIMAVAASLAESGPVSPLWLLTVYLIIVCGELVVAPVGLSLAAQVAPPGFSSQMIGLFWLFAAVGAATGGQLAGITAVVSDATFYLVLGGVGLAVAAALAFSVRSLTRRLADEPVPDKPTTTQSPVEGVTSLH	MISFFTKTTDMMTSKKRWTALVVLAVSLFVVTMDMTILIMALPELVRELDPSGTQQLWIVDIYSLVLAGFIIPLSAFADKWGRKKALLTGFALFGLVSLAIFFAESAEFVIAIRFLLGIAGALIMPTTLSMIRVIFENPKERATALAVWSIASSIGAVFGPIIGGALLEQFSWHSAFLINVPFAIIAVVAGLFLLPESKLSKEKSHSWDIPSTILSIAGMIGLVWSIKEFSKEGLADIIPWVVIVLAITMIVIFVKRNLSSSDPMLDVRLFKKRSFSAGTIAAFMTMFAMASVLLLASQWLQVVEELSPFKAGLYLLPMAIGDMVFAPIAPGLAARFGPKIVLPSGIGIAAIGMFIMYFFGHPLSYSTMALALILVGAGMASLAVASALIMLETPTSKAGNAAAVEESMYDLGNVFGVAVLGSLSSMLYRVFLDISSFSSKGIVGDLAHVAEESVVGAVEVAKATGIKQLANEAVTSFNDAFVATALVGGIIMIIISIVVYLLIPKSLDITKQK	98.83	gnl|BL_ORD_ID|339|hsp_num:0	372			363	537	
BGC0001062.1|TLN-05220_26 # 26935 # 27147 # 1 # ID=1_26;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=7bp;gc_cont=0.718	BGC0001062.1|TLN-05220_26 	26935	27147	+	Loose	550	25.0238	y56 beta-lactamase	31.48	3003558	protein homolog model	n/a	n/a	cephalosporin; penam; penem	antibiotic inactivation	BlaA beta-lactamase	GTGAGGACGCTGGTGGCAATTCTGATCGGCCTCGTCGCCGGGTTCTTCGCCGGACTGGTGGTCGACCAGATCATCGGCGTCATCGGCCTGCTCACCTCGGGCGACCTGGGCGGCTTCCGGTTCCTGCCGCTCGTCCTCGCCGCCGTCGGCGCGGTCGTCGCGGTCGTCGTCGACCGGCAGCGGCAGCACCGGAACGCCCCGCCACGGCGCTGA	MRTLVAILIGLVAGFFAGLVVDQIIGVIGLLTSGDLGGFRFLPLVLAAVGAVVAVVVDRQRQHRNAPPRR	MKHSSLRRALLLAGITLPLVNFSLPTWAAAIPGSLDKQLAALEHSANGRLGIAMINTGNGTKILYRGARRFPFCSTFKFMLAAAVLGQSQSQPNLLNKHINYHESDLLSYAPITRKNLAHGMTVSELCAATIQYSDNTAANLLLKELGGLAAVNQFARSIGDQMFRLDRWEPDLNTALPNDPRDTTTPAAMAASINKLVLGDALHPAQRSQLTAWLKGNTTGDATIRAGAPTDWIVGDKTGSGDYGTTNDIAVLWPTKGAPIVLVVYFTQREKDAKPRRDVLASATKIILSQIS	23.81	gnl|BL_ORD_ID|908|hsp_num:0	980			681	837	ticarcillin
BGC0001062.1|TLN-05220_27 # 27307 # 28935 # 1 # ID=1_27;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.737	BGC0001062.1|TLN-05220_27 	27307	28935	+	Loose	550	140.198	Nocardia farcinica rox	33.9	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGTACGACGAGACAACACCAGTACTGATCGTCGGGGGTGGGGTGGTGGGGCTCTCCACCTCCCTGTTCCTGTCCGCGCACGGCGTCCGGTCGGTCCTCGTCGAACGTCACCCGGGCACCGCCATCCACCCCCGCGCCTGGGGCTGGTACCCGCGCACGCTGGAGCTGTACCGCTCCGTCGGGTTGACCGACGCGATCTACGCCGAGAGCGCCGGCTTCGCCGGTCACGTCCTCAACGGCAAGGTCGAGTCGCTGACCGGCCGGGAGATCCACATGTCCCGGATCCCCGACGAGGAGGACGTCAGCGACATCAGCCCGATCGAGCGGCTGGTCTCGCTGCCGCAGGACCGGATCGAACCGCTGGTCCTGGACCGGGCACACGAGCTGGGCGCCGACATCCGCTTCGGTGTGGAGCTGGTCGACCTCGCCCGGGACGACGAGGGCGTCACCGCCACCGTCCAGGACCGGAAGACCGGGACGCGCCGGATCATCCGGGCGGAGTACCTGGTCGCCGCGGACGGCACGCACAGCCCGATCCGGGAGCGGCTCGGCATCCGGCGGCACGGGCGCGGTGTGGTCCGCCACCAGATGAGCATCCTGTTCCGGGCCGACCTGACCGGCCCGCTCGCCGGCCGCCGGTTCGCCATCTGCCAGGTCGAGAACGACCGGGTGGAGGGCATCCTCGGGCACGACGACTCGCTGGGGCAGGGCACCCTGATCGTCACCTACCACCCGGAGAAGGGCGAACGCCCGGAGGACTTCACCGACGAGCGCTGCGTCGAGCTGGTCCGGGCCGCGGTGGGCGTACCGGACCTCGAGGTCGGGCTGCGCAGCGTCATGCCGTGGGAGATGGGCGCACTGGTCGCCGAGCGGTTCACCGACGGGCGGATCTTCCTCGTCGGCGACGCCGCGCACGTGGTGCCGCCGGTCGGCGGGTACGGCGCGAACACCGGCATCCACGACGCGCACAACCTGGCCTGGAAGCTGCACGCCGTGCTGACCGGTCAGGCATCCCCCGCCCTGCTGGGCACCTACGACGCCGAGCGCCACCCGGTCGGCGTCACCGTGATGACCCAGGCCGGACTCCGCCTGGCCACCCGGGGCGGCTTCGCCACCGGCGAGCAGAAGGCCGCCGTCCGGGACACCCTGATGGTGACCTTCGGCTACGTCTACGACTCGTCCGCCGTGGCCGCCGAACCGGGCGACACCGTCCCCGCCGCCCCGCCCGGGCCGGGCGGGGTCCGCACCGCCGCCCTGGTCGACCCGCGCCAGCTCGGCGGCCGGCCCGGCACCCGCGCGCCGCACGTGTGGCTGCGCCGGGACGGGGAGCGGATCTCCACCCTGGACCTGTTCGGCCGGCGGCCGGTGCTGCTACTCGGCTCGGCCGGCGAGCCGTGGCGCGTCGCCGCGACGGCCGCCGCGAAGCGCCTCGGCGTCGACCTCGACATCCACCGGATCGGCGCGGACCTCGTCGAGGACGACCGACCCTGGCACGACACGTACGGCGTCGCGCCGCAGGGGGCGGTGCTCGTCCGGCCGGACGGCTTCGTCTGCTGGCGTTCCCCGGCCGACGCCGAGGCCACCGAGTCCACCGTCGAACGGGTACTGGGCGCCCTGCTGCACCGCTGA	MYDETTPVLIVGGGVVGLSTSLFLSAHGVRSVLVERHPGTAIHPRAWGWYPRTLELYRSVGLTDAIYAESAGFAGHVLNGKVESLTGREIHMSRIPDEEDVSDISPIERLVSLPQDRIEPLVLDRAHELGADIRFGVELVDLARDDEGVTATVQDRKTGTRRIIRAEYLVAADGTHSPIRERLGIRRHGRGVVRHQMSILFRADLTGPLAGRRFAICQVENDRVEGILGHDDSLGQGTLIVTYHPEKGERPEDFTDERCVELVRAAVGVPDLEVGLRSVMPWEMGALVAERFTDGRIFLVGDAAHVVPPVGGYGANTGIHDAHNLAWKLHAVLTGQASPALLGTYDAERHPVGVTVMTQAGLRLATRGGFATGEQKAAVRDTLMVTFGYVYDSSAVAAEPGDTVPAAPPGPGGVRTAALVDPRQLGGRPGTRAPHVWLRRDGERISTLDLFGRRPVLLLGSAGEPWRVAATAAAKRLGVDLDIHRIGADLVEDDRPWHDTYGVAPQGAVLVRPDGFVCWRSPADAEATESTVERVLGALLHR	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	114.59	gnl|BL_ORD_ID|4834|hsp_num:0	5821			9	993	rifampin
BGC0001062.1|TLN-05220_29 # 30795 # 38585 # 1 # ID=1_29;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.754	BGC0001062.1|TLN-05220_29 	30795	38585	+	Loose	660	88.1965	MexS	37.13	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGTCGCGCACAGCCTGGCCACCACGCGGACCCGGTTCGACCACCGGGCCGTGGTGGTCGCCGGGGACGTCGTCGAGGCGCGGACGGCGCTGACCGCGCTGGCCCAGGGGTCACCCGACGGCGGGCTGGTCACCGGCACCCGCACCCCGGGGAAGGTGGTCTTCGCGTTCCCCGGCCAGGGGTCGCAGTGGGTCGGCATGGCGCTGGGACTGCTCGACCGGCATCCGGTGTTCACCGCGCAGCTGCGCCGCTGCGCCGACGCGCTCGCCCCGTACACCGACTGGAACCTGATCGACGTCCTGCGCGGCGAGCCGGACACCCCACCGCTGGACCGGGTGGACGTGCTCCAGCCGGCGCTCTGGGCGATGATCATCTCGCTGGCGGAGACCTGGCGGGCGCACGGCGTCGAGCCGGACGCGGTGATCGGCCACAGCCAGGGCGAGATCGCCGCCGCGTACGTCGCCGGAGCGCTCACGCTCGACGAGTCGGCACGGCTCGTCGCCCGCCGCGCCCAGGCGATCACCGCGATCGCCGGCACCGGCGGCATGGTCTCCATCCCACTTCCGTCGGACCAGGTCGACCTGACCCCGTGGGCCGGGCGGCTGCACGTCGGCGCGCTGAACGGGCCGTACTCCACGGTGGTCTCCGGCGACCTGGACGCCCTCGACGAGATCACCGCCGCGCACGCGGAGCGGGGGATCACCTGCCGCCGGGTCAACATCGACTACGCCTCGCACACCCATCACGTGGAGCCGCTGCGGGAGCGGTGGGACGAGATGCTCGGCGAGCTGCGGCCGACCGCCGCGCGGATCCCGTTCTGGTCCACGGTGACCGCCGCTCCGGTCGACGGCACCGCCCTGACCGCGGACTACTGGTACGGGAACCTGCGTAACCCGGTCCGCCTCGACGAGACCGTCCGGGCCCTGGCGGCGGCTGGGCACACCCACTTCGTCGAACCCAGCCCGCACCCGGTGCTGACCGTCGGCATCCAGGACAGTCTGGACGCCAGCGACGTCGCCGGCACCACCACCGGCACCCTCAAGCGTGGTGACGGCGGCCCGCGCCGGCTGCTGCTCTCGTTGGCCACCGTGCACACCCGCACCGGGCGGACGCCGATCCTCGCCGCCGACCCGGAGCACGTCCCGGACGGCACGGTCGACCTGCCCACGTACCCGTTCCAGCGCCAGTCGTACTGGATCGCCGCCGGGCCGGCCCCGACGGGGCCCGCGCCGGGTGGTGCGGCGCACCCGGTCCGGGACGCGGAGCCCGTCCGGGGCGCGCAGCCCGGGCTGACCGGCACGCTGGCCGAACGGCTCGCCCTGCTGCCCGCGCCCGAGCAGTCCCGGCTGACGCTCGATCTGGTCCGCAAGAACGCCGCGGCGGTGCTCGGCCACGCCTCCGACACCGCGATCGGGGTCGGCCTCTCCTTCCGAGACCTGGGCTTCGACTCGGTGCTCTCGCTGGAGCTGCGCAACCGCCTCGCGGCGGCCACCGGGCTGCGGCTCGCCTCCGGCCTGCTCTTCAACCACCCGACCCCGGCCACCCTCGCCGGGCACCTGCGCGACCAACTGGCCGGCGGCGGCGTCGACGCGGCGGCCACCCGGGCGGACGCGGACGCGGACGAACCGATCGCGGTGGTCGCCATCGGCTGCCGCTACCCCGGCGACGTCCGCTCCTCGGAGGACCTGTGGCGGCTGGTCGCCGAGGGCGTCGACGCGATCGGCGAGCTCCCCACCAACCGGGGCTGGGACCTGGAGGGACTGTTCGACCCGGAGCCCGGCGCGCCCGGAAAGTCGTACGCCCGGCACGGCGGCTTCCTGCACCGGGCCGACGAGTTCGACGAGGAGTTCTTCGGGATCAGCCCGCGTGAGGCCGCCGCCATGGACCCGCAGCAGCGGTTGCTGCTGGAGACCTCGTGGGAGGCGTTCGAGCGGGCCGGCATCGACCCGACCGCGCTGCGCGGCAGCCGCACCGGCGTGTTCATGGGGCTGATGTCCCAGGAGTACGGACCACGCCTGTACGAGACGTCGGCCGGCTCCGACGGGTACCGGCTCACCGGCAGCACCGCCAGCGTCGCCTCCGGGCGGATCTCGTACGTCTTCGGCTTCGAGGGCCCGGCGTTCACGGTGGACACCGCCTGCTCCTCGTCGCTGGTGGCGATCCACCTCGCGGTGCAGTCGCTGCGCCGGGGCGAGAGCGACCTGGCGGTCGCGGGCGGGGCGTGCGTAATGTCCTCGCCCGGGATCTTCGTCGAGTTCAGCCGGCAGCGCGGTCTCGCGCCGGACGGGCGCTGCAAGGCGTTCGGGGCCGGGGCGGACGGCACCGGCTGGGCCGAGGGCGCCGGGGTGCTGCTGCTGGAGCGGCTCTCCGACGCGAGCCGCAACGGCCACCGGGTACTCGCGGTGATCCGGGGCAGCGCGATCAACTCCGACGGGGCCAGCAACGGGCTCACCGCCCCGAACGGCCCGTCTCAGGAGCGGCTGATCCGGGACGCGCTGGCGGACGCCGGCCTCTCCCCCGCCGACGTGGACGCCGTCGAGGCGCACGGCACCGGCACCCAGCTCGGCGACCCGATCGAGGCCGGCGCGCTCCTCGCCACGTACGGGCAGGGTCGGCCGGCGGACCGGCCGCTGCGGCTGGGCTCGCTGAAGTCGAACATCGGGCACAGCCAGGCGGCGGCCGGTGTGGGCGGCGTGATCAAGATGATCGAGGCGCTCCGGCACGACCTCCTGCCGCCCACCCTGCACGCGGCCGAGCCCTCGCCACATGTGGACTGGTCGTCCGGCGCGGTCAGGCTGCTCACCGAGACGGTGCCGTGGCCACGCGACGAGCGGCCCCGCCGGGGCGCGGTCTCCTCGTTCGGCATCAGCGGCACCAACGCGCACGTGATCCTGGAGGAGGCCCCGGCCGACGCGGACGCCGCCCCGGCCGACGGCGACGACGTCCCGCCGGCCATGGCGGGCGCGGTCGCCCTGCCCCTGTCGGCGCGTGGCCCGGCCGCTCTGCGCGACCAGGCCGCCAACCTGGCCCGGCACCTGGACGCCCACCCCGACCTCGACCCGGCCGTGGTCGCGCACACCCTGGCCACCACCCGGGCGCGGTTCGACCACCGCGCGGTCGTCGTCGCCGCCGACCCGGACGCCACCCGCGAGGCGCTCACCGCCCTCGCCAAGGGACGGTCCGCACCGAACCTGGTCACCGGCACCCCGACCGAGGGGAAGACCGTCTTCGTCTTCCCGGGGCAGGGGTCGCAGTGGGTCGGCATGGCGCTGGGACTGCTCGACCGGCATCCGGTGTTCACCGCGCAGCTGCGCCGCTGCGCCGACGCGCTCGCCCCGTACACCGACTGGAACCTGATCGACGTCCTGCGCGGCGAGCCGGACACCCCACCGCTGGACCGGGTGGACGTCATCCAGCCCGTCCTCTGGGCCATGATGATCTCCCTGGCGGAGACCTGGCGGGCGCACGGCGTCGAGCCGGACGCGGTGATCGGCCACAGCCAGGGCGAGATCGCCGCCGCGTACGTCGCCGGAGCCCTCACCCTCGACGACTCGGCCAGGGTCGTGGCGCGCCGGTCGCAGGCGATCACCGCACTGGCCGGCACCGGCGGGATGGTCTCCGTGCCGCTGCCGGTGGAGCAGGTCGACCTGACCCCGTGGGACGGGCGGATCCACGTCGCGGCGATCAACGGGCCACACTCCACGGTGGTCGCCGGCGAGGCCGCCGCCCTCGACGACCTGGTCACGAGCTTCCAGGCCCGGGACGTCAACGCCCGCCGGATCGACGTCGACTACGCCTCGCACACCCCGTTCGTGGAGCCGATCCGGGACCAGGTGCACGAACTGCTCGGCGAGATCCGGCCCCGGGCGTCGCGGATCCCGTTCTGGTCCACGTACACCGGCGGCCTGCTGGACACCACCGAGCTGGGCACCGGGTACTGGTTCCAGAACCTGCGCAACACGGTCCGGTTCGCCGAGACCGTCCGAGGGCTGGCCGCCGCCGGGCACACCCATTTCGTCGAGACCAGCCCGCACCCGGTGCTCACCATCGGCATCCAGGACACCCTGGACGCCGCCGACCACCCCGGCACCACCACCGGGACGCTGAAGCGCGGCGAGGGCACCGCCGCCCGGCTGCTGCTCTCGCTGGCCCACGTGCACACCCACACCGGGCACCGGCCCCGGCTGGTCGCCGATCCGACGTCCGAGCCGCGCGGCACGGTCGACCTGCCCACGTACCCGTTCCAGCCGCACCGGCACTGGCTCGCCGCGCCGAGCGGGGCGGCCCCGGCCCGGGACGCCGGGCACCGGTTCCTCGACGCCGAGATCGACCTGGCCGGCGACGCCGGGGTGCTGCTCTCCGGGCGGCTGTCCCGGCGCACGCATCCCTGGCTGGTCGACCACGCGGTACGCGACACCGTGCTGCTCCCCGGCACCGCCCTGGTCGACCTGGCCTCGTACGCCGCCGACCGGGCCGGCTGCGGCGTGGTCGACGACCTGGTCCTGGAGGCGCCACTGGTGCTGCCGGTCACCGGCGGCGTGGAGATCCAGGTGAGCGTCTCCCCCGGCGACGACCCGGAGCGGCGGACGCTGACCGTCCACTCCCGGCCCGTCGCCGATGGCACCGGGACCGACCGGACGTGGGTCCGCAACGCCACCGGCACGCTGGCCGGGACGGAGCCGGGCGACGGGCCGCGCCTGGACGAGTGGCCCCCGGCACGGGCGACACCGTGGGACCTGACCGACGCCTACCCGCGGCTGGCCGACGCCGGCTACCGGTACGGGCCGACCTTCCGTGGCCTGCACCGGGCCTGGCGGGACGGCGACGACCTGTACGCCGAGGTACGGCTCGTCGACGACCAGTCCGTCGCCGGCTTCCACGTGCACCCGGCGCTGCTCGACGCCGCGCTGCACCCGCTCGTGTTGAGCCTGCTCGACGGGGACACCCGGGGTGGCATCGCCCTGCCGTTCGCCTGGAGCGGCGTCCGGGTGCACGCCGTGGAGGCGACCGCGCTGCGGGTGCACGTCCGGCGCACCGGCGAACTGAGCGCGGCGCTGACCCTGACCGACGGGTCCGGGGCGCCGGTGGCCGAGGTGGAGTCGCTGACCCTGCAACCCGCCGCCTCCGCCCAGCTCTCCGCCGCCGCAGCGCACCGCGACTCGCTGCTGGAGGTGGCCTGGACCGAGGTGACCGCACCACCGACCGCCGGCACCGTCCGGCTGGCGGCGCTCGGCGAGAGCGACCTGGACGCGGCCGGCGCGACGGTCTATCCGGACCTCGCCGCACTGCTCGCCGCGGTCGAGGCCGGGGCACGGGTGCCGGACGTCGTGGTGGCCACCGCCGGGGCACCGGAACCGGAGATGGTCCCGGCGACCCACTCGGCGGTCACCGCCGCGCTGGACCTGCTCCAGCAGTGGCTGGCCAGCGACCGGCTGGACGCCTCCCGCCTGGTGCTGACCACGTTCCGGGCGGTCGCCGCCGACGCGGGCGAGCCGGTCCGGGACCCGGCGACCACGGCGGTGTGGGGGTTGCTGCGCACCGCGCAGACCGAACACCCCGGCCGGTTCGTCCTGGTCGACCTGGACACCCCGTCGCACCTGCGGGTGCCCGCCGCGGTCGCCACCGGCGAGCCGCAGGTGGCGGTCCGGGGGGACACGCTGCGCGTGCCCCGGCTGGCCCGCACCGGCACCGAGCAGACCCTGGTCGTACCGGAGACGACGGACTGGCGACTGGTGGCCGAACCACGCGGCACCATCGACAACCTGGCCCTGGTCGGCCCTGCGGGGACGGACCGTCCACTGGCCGACGGGGAGGTCCGGATCGCCGTCCGGGCCGCCGGCCTCAACTTCCGGGACGTGCTGATCTCCCTCGACATGTACCCGGGCGCGGCGACGATGGGCTGCGAGGCGGCCGGGGTGGTCGTCGAGGTCGGTGCCGGCGTGACCGACCTGGCCCCCGGCGACCGGGTGATGGGTCTCTTCCCCGAGGGGGCCTTCGGCCCGGTCGCGGTGGCCGACCACCGGCTGCTCGCCCGCATCCCGGCGGGCTGGACGTTCGCGCTCGCCGCCAGCGTGCCGACGGTCTTCCTGACCGCCTGGTACGGCCTGGTCGACCTGGCCGACCTGCGGTCCGGCGAACGGGTGCTGATCCACGCCGCCACCGGCGGTGTGGGGATGGCGGCGGTGCAGGTCGCCCGGCACCTGGGCGCCGAGGTCTTCGCCACGGCCAGCCCGCCGAAGTGGGACACGCTGGTGGAGGCGGGCTTCGACGACGCGCACATCGCCAACTCCCGCACCCTGGACTTCGAGCAGTGGTTCGCCGACGCCACCGGGCAGGAGGGCGTGGACGTGGTGCTCAACTCGCTGGCCGGCGAGTTCACCGACGCCTCGCTGCGGTTGCTGCGCCGGGGCGGTCGGTTCGTCGAGATGGGCAAGACCGACATCCGCCCCGCCGAGCGGGTCGCCGCCGACCACCCCGGCGTGACGTACCGGTTCTTCGACCTGCTGACCGTGGACCCGGACCGGATCCGGGGGATGTTCGCCGCCCTGATGGACCTCTTCGACGCGGGCGTGCTGGAGCCGAGCCCGATCACCACCTGGCCGATCGACCGGGCCCCGGCGGCCTTCCGCCACCTCCAGCAGGCCCGGCACGTCGGCAAGCTGGTGCTGACCCTGCCCGGCGGGCTCGACCCGGAGGGGACCGTCCTGATCACCGGCGGCACCGGCACGCTGGGCCGCCTGCTGGCCCGGCACCTGGTCACCCGGCACTCCGTCCGGCACCTGCTGCTGACCGGCCGGCGCGGCCGGGACGCGGACGGGGTGGCCGAGCTGGAGAAGGAGCTGGCCGGGCTGGGCGCGGAGGTGACCGTCGCGGCCTGCGACGTCGCCGACCGGGAGGCGCTGGCCCGGGTGCTGGACGCCGTGCCGGCGGCGCACCCGCTCACGGCGGTCGTGCACACCGCCGGCCTGCTCGACGACGCCACGGTCGAGGCACTCGCACCGGACCAGGTGGCCCGCGTCCTGCGCCCCAAGGTGGACGGTTCCTGGCACCTGCACGACCTGACCCGGGACCGGCCGCTGGATGCGTTCGTGCTCTTCTCCTCGGTCGCCGGGACGATCGGGCTGGCCGGTCAGGGCAACTACGCCGCCGCGAACGCGTTCCTCGACGGGCTGGCGGCGCTACGCCGGTCCACCGGCCGCACCGCCACCTCGTTGGCCTGGGGTCTGTGGGCCGAGTCCAGCGGGATGACGGGGCATCTCGCCGAGGCCGACCTGGCCCGGATGAGCCGCGCCGGCGTCGCCGGTCTCTCCAACGAGGAGGGTCTCGCCCTGTTCGACCTGGCCGTCGCCCGAGACCAGGCCCACCTGGTGCCGGTCCGGTTGGACCGGGCCGCGCTGCGCAGCGCGGCCCGGGACACCATGCCCGGGATGTTCCGGGACCTCGTCCCGCCGCCCGGACGGCGGGTCGTCGAGCGGGTGACGCGCGGCACCGGGTCGTCCTCCTCCTGGGCCGACCAGCTCGCCCAACTGCCCCAGGAGCGCCGGCACGACGCCCTCGTGCGACTGTTGAGCACCGAGGTCGCCTCGGTGCTGGGCCGCAGCGGCGGGATCGACCACGGGCAGACGTTCCGCGACCTCGGCTTCGACTCGCTCGCCTCGGTGGAGCTGCGCAATCGGCTCCGGACCGCCACCGGCCTCCGGCTGCCCGCCGGGGTGGTCTTCGAGTACCCCCGGGTGGGCGAGCTGGCGGAGGTTCTGCTCGACCAGGTGCTGGCGGCGGGGAAGGCGTGA	VVAHSLATTRTRFDHRAVVVAGDVVEARTALTALAQGSPDGGLVTGTRTPGKVVFAFPGQGSQWVGMALGLLDRHPVFTAQLRRCADALAPYTDWNLIDVLRGEPDTPPLDRVDVLQPALWAMIISLAETWRAHGVEPDAVIGHSQGEIAAAYVAGALTLDESARLVARRAQAITAIAGTGGMVSIPLPSDQVDLTPWAGRLHVGALNGPYSTVVSGDLDALDEITAAHAERGITCRRVNIDYASHTHHVEPLRERWDEMLGELRPTAARIPFWSTVTAAPVDGTALTADYWYGNLRNPVRLDETVRALAAAGHTHFVEPSPHPVLTVGIQDSLDASDVAGTTTGTLKRGDGGPRRLLLSLATVHTRTGRTPILAADPEHVPDGTVDLPTYPFQRQSYWIAAGPAPTGPAPGGAAHPVRDAEPVRGAQPGLTGTLAERLALLPAPEQSRLTLDLVRKNAAAVLGHASDTAIGVGLSFRDLGFDSVLSLELRNRLAAATGLRLASGLLFNHPTPATLAGHLRDQLAGGGVDAAATRADADADEPIAVVAIGCRYPGDVRSSEDLWRLVAEGVDAIGELPTNRGWDLEGLFDPEPGAPGKSYARHGGFLHRADEFDEEFFGISPREAAAMDPQQRLLLETSWEAFERAGIDPTALRGSRTGVFMGLMSQEYGPRLYETSAGSDGYRLTGSTASVASGRISYVFGFEGPAFTVDTACSSSLVAIHLAVQSLRRGESDLAVAGGACVMSSPGIFVEFSRQRGLAPDGRCKAFGAGADGTGWAEGAGVLLLERLSDASRNGHRVLAVIRGSAINSDGASNGLTAPNGPSQERLIRDALADAGLSPADVDAVEAHGTGTQLGDPIEAGALLATYGQGRPADRPLRLGSLKSNIGHSQAAAGVGGVIKMIEALRHDLLPPTLHAAEPSPHVDWSSGAVRLLTETVPWPRDERPRRGAVSSFGISGTNAHVILEEAPADADAAPADGDDVPPAMAGAVALPLSARGPAALRDQAANLARHLDAHPDLDPAVVAHTLATTRARFDHRAVVVAADPDATREALTALAKGRSAPNLVTGTPTEGKTVFVFPGQGSQWVGMALGLLDRHPVFTAQLRRCADALAPYTDWNLIDVLRGEPDTPPLDRVDVIQPVLWAMMISLAETWRAHGVEPDAVIGHSQGEIAAAYVAGALTLDDSARVVARRSQAITALAGTGGMVSVPLPVEQVDLTPWDGRIHVAAINGPHSTVVAGEAAALDDLVTSFQARDVNARRIDVDYASHTPFVEPIRDQVHELLGEIRPRASRIPFWSTYTGGLLDTTELGTGYWFQNLRNTVRFAETVRGLAAAGHTHFVETSPHPVLTIGIQDTLDAADHPGTTTGTLKRGEGTAARLLLSLAHVHTHTGHRPRLVADPTSEPRGTVDLPTYPFQPHRHWLAAPSGAAPARDAGHRFLDAEIDLAGDAGVLLSGRLSRRTHPWLVDHAVRDTVLLPGTALVDLASYAADRAGCGVVDDLVLEAPLVLPVTGGVEIQVSVSPGDDPERRTLTVHSRPVADGTGTDRTWVRNATGTLAGTEPGDGPRLDEWPPARATPWDLTDAYPRLADAGYRYGPTFRGLHRAWRDGDDLYAEVRLVDDQSVAGFHVHPALLDAALHPLVLSLLDGDTRGGIALPFAWSGVRVHAVEATALRVHVRRTGELSAALTLTDGSGAPVAEVESLTLQPAASAQLSAAAAHRDSLLEVAWTEVTAPPTAGTVRLAALGESDLDAAGATVYPDLAALLAAVEAGARVPDVVVATAGAPEPEMVPATHSAVTAALDLLQQWLASDRLDASRLVLTTFRAVAADAGEPVRDPATTAVWGLLRTAQTEHPGRFVLVDLDTPSHLRVPAAVATGEPQVAVRGDTLRVPRLARTGTEQTLVVPETTDWRLVAEPRGTIDNLALVGPAGTDRPLADGEVRIAVRAAGLNFRDVLISLDMYPGAATMGCEAAGVVVEVGAGVTDLAPGDRVMGLFPEGAFGPVAVADHRLLARIPAGWTFALAASVPTVFLTAWYGLVDLADLRSGERVLIHAATGGVGMAAVQVARHLGAEVFATASPPKWDTLVEAGFDDAHIANSRTLDFEQWFADATGQEGVDVVLNSLAGEFTDASLRLLRRGGRFVEMGKTDIRPAERVAADHPGVTYRFFDLLTVDPDRIRGMFAALMDLFDAGVLEPSPITTWPIDRAPAAFRHLQQARHVGKLVLTLPGGLDPEGTVLITGGTGTLGRLLARHLVTRHSVRHLLLTGRRGRDADGVAELEKELAGLGAEVTVAACDVADREALARVLDAVPAAHPLTAVVHTAGLLDDATVEALAPDQVARVLRPKVDGSWHLHDLTRDRPLDAFVLFSSVAGTIGLAGQGNYAAANAFLDGLAALRRSTGRTATSLAWGLWAESSGMTGHLAEADLARMSRAGVAGLSNEEGLALFDLAVARDQAHLVPVRLDRAALRSAARDTMPGMFRDLVPPPGRRVVERVTRGTGSSSSWADQLAQLPQERRHDALVRLLSTEVASVLGRSGGIDHGQTFRDLGFDSLASVELRNRLRTATGLRLPAGVVFEYPRVGELAEVLLDQVLAAGKA	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	765.78	gnl|BL_ORD_ID|1039|hsp_num:0	1041			78	672	ciprofloxacin; trimethoprim; chloramphenicol
BGC0001062.1|TLN-05220_30 # 38954 # 39754 # -1 # ID=1_30;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.707	BGC0001062.1|TLN-05220_30 	38954	39754	-	Loose	400	32.3426	vanR gene in vanI cluster	29.17	3003728	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	GTGCTTGCGCTTCTCGCTATTTGTGCCAATCGCGTCGTCCGTAACGAACAGATCATCGAAGAGCTGTGGGAGAACAGTCCGCCCACCAGCGTCACCACCACCCTCCAGACGTACGTCTACCAACTCCGCAAACATCTGCAGCGGGCACTCACCCCCCAGTCCGGCGGCACCGGGCCGGGCTCCGCGCCCACGTCGGAGTTGCGGACGTTCGCCGGCGGTTACATGCTCTCCCTCGCTCCCGAGGCACTCGACTCGCTGCGCTTCGAACAACTGGTGGCGCAGGGGCGCGCGGCGCTCGAGTCCGGTCGTACGGAGGCCGCGGCCCGGATCCTCCGGGACGCTCTGGCCCTCTGGCGGGGGCCGGCGCTGGTGGACGTCACGCCGGGGCCCATCCTCCAGGTGGAGGTGCTGCGGCTGGAGGAGATGAGCAAGAGCGCCCTGGAACTGCGCATCGAGGCGGACCTGCTGCTGGGGCGTCACCACGAACTCCTCAGCGAGCTGGTCGGACTCTCCGCGCGGCAGCCCACCCACGAGGGGTTCCAGGCCAAGCTGATGCTCGCGCTCTACCGCGCCGGGCGCCGCTCCGAGGCGCTCGGTGTCTACCAGGGGGCCCGCAAGGCCCTGGTAGCGGAGCTGGGGGTGGACCCCTCGGGCGACCTGCAACGCCTGCACCGGGCCATCCTCGAAGGTGACCCGAGCCTCAGCGAGGCCGGTCCGCCGCCCATCGGGCTGGAGTCCCTGGCGATGTCCATCCCCCGGCAGCGGCGGCTGGAGCACCGGCAGGTCGGTGCGGTGCAGTAG	MLALLAICANRVVRNEQIIEELWENSPPTSVTTTLQTYVYQLRKHLQRALTPQSGGTGPGSAPTSELRTFAGGYMLSLAPEALDSLRFEQLVAQGRAALESGRTEAAARILRDALALWRGPALVDVTPGPILQVEVLRLEEMSKSALELRIEADLLLGRHHELLSELVGLSARQPTHEGFQAKLMLALYRAGRRSEALGVYQGARKALVAELGVDPSGDLQRLHRAILEGDPSLSEAGPPPIGLESLAMSIPRQRRLEHRQVGAVQ	MAANILIVDDEQAIADLVEVYLKNENYNLFKFYNGKDALDCIEKEKLDLAILDVMLPDVDGFSICRQIREKHNFPVIMLTAKEEEIDKITGLTLGADDYITKPFRPLELIARVKAQLRRFTKYNSAEPNQEEHVIAFSGLVLDMDTHECTLNEKKLSLTPTEFSILWVLCSNRGRVVSSEELFSEVWGDKYFTNSNNTVMVHIRHLREKMQDSAEHPKYIKTVWGVGYKIEK	114.66	gnl|BL_ORD_ID|2065|hsp_num:0	2246			495	639	vancomycin; teicoplanin
